| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.05e-05 | 130 | 212 | 9 | GO:0005200 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ITGA6 ITGA1 ADAM10 TENM2 PTPRO CNTN5 KDR HSPA5 FLNA DSC2 DBNL NIBAN2 PTPRT TENM3 EGFR CDH7 CDH12 PHLDB2 CDH18 | 2.28e-05 | 599 | 212 | 19 | GO:0050839 |
| GeneOntologyMolecularFunction | cadherin binding | ITGA6 PTPRO KDR HSPA5 FLNA DBNL NIBAN2 PTPRT EGFR CDH7 CDH12 PHLDB2 CDH18 | 7.22e-05 | 339 | 212 | 13 | GO:0045296 |
| GeneOntologyMolecularFunction | glycylpeptide N-tetradecanoyltransferase activity | 1.12e-04 | 2 | 212 | 2 | GO:0004379 | |
| GeneOntologyMolecularFunction | Atg12 transferase activity | 1.12e-04 | 2 | 212 | 2 | GO:0019777 | |
| GeneOntologyMolecularFunction | peptidyl-lysine N6-myristoyltransferase activity | 1.12e-04 | 2 | 212 | 2 | GO:0018030 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 1.81e-04 | 78 | 212 | 6 | GO:0003725 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | TUBA3E TUBA8 TUBA4A TUBA3C AK3 TUBA1B TUBA1A DNM1 CNGA4 DNM2 ADSS1 MRAS TUBA3D TUBA1C | 2.64e-04 | 439 | 212 | 14 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | TUBA3E TUBA8 TUBA4A TUBA3C AK3 TUBA1B TUBA1A DNM1 CNGA4 DNM2 ADSS1 MRAS TUBA3D TUBA1C | 2.64e-04 | 439 | 212 | 14 | GO:0019001 |
| GeneOntologyMolecularFunction | GTP binding | TUBA3E TUBA8 TUBA4A TUBA3C AK3 TUBA1B TUBA1A DNM1 DNM2 ADSS1 MRAS TUBA3D TUBA1C | 3.40e-04 | 397 | 212 | 13 | GO:0005525 |
| GeneOntologyMolecularFunction | kinase binding | NBEAL1 PPP1R12B PER1 ADAM10 TUBA4A LIN7B PTK2B AP2A1 NBEAL2 MAP3K11 DNM1 NCK2 DNM2 FLNA ADCY4 NTRK2 CEP192 BCAR1 GSN EGFR STAU2 EP300 | 6.64e-04 | 969 | 212 | 22 | GO:0019900 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CADM3 CADM2 FAT2 CNTN5 DSC2 PCDHGB7 DSG1 PTPRT HMCN1 TENM3 DSG4 CDH7 CDH12 CDH18 | 7.90e-09 | 187 | 210 | 14 | GO:0007156 |
| GeneOntologyBiologicalProcess | neuron projection development | UNC5B ITGA6 ITGA1 ADAM10 TENM2 PHGDH PTK2B AP2A1 TUBA1A PTPRO GLI2 CNTN5 AGT UGT8 COBL KDR HSPA5 PLXNA2 NCK2 DNM2 FLNA NTRK2 DBNL LAMA2 NIBAN2 CRMP1 SEMA3D PPP2R5D TENM3 EGFR STAU2 TMEM30A PARD3 ULK2 EP300 | 9.08e-08 | 1285 | 210 | 35 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CADM3 TENM2 CADM2 FAT2 CNTN5 MPZ DSC2 PCDHGB7 DSG1 PTPRT HMCN1 TENM3 DSG4 CDH7 CDH12 CDH18 | 1.45e-07 | 313 | 210 | 16 | GO:0098742 |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | ITGA6 PTK2B AP2A1 AGT COBL HSPA5 FLNA NTRK2 DBNL PPP2R5D TENM3 STAU2 TMEM30A EP300 | 2.84e-07 | 249 | 210 | 14 | GO:0010976 |
| GeneOntologyBiologicalProcess | neuron development | UNC5B ITGA6 ITGA1 ADAM10 TENM2 PHGDH PTK2B AP2A1 TUBA1A PTPRO GLI2 CNTN5 AGT UGT8 COBL KDR HSPA5 PLXNA2 NCK2 DNM2 FLNA NTRK2 DBNL LAMA2 NIBAN2 CRMP1 SEMA3D PPP2R5D TENM3 EGFR STAU2 TMEM30A PARD3 ULK2 EP300 | 1.90e-06 | 1463 | 210 | 35 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell junction organization | AGO2 ITGA6 F2R ADAM10 PTK2B TUBA1A PTPRO CNTN5 AGT UGT8 KDR MPZ FLNA DSG1 NTRK2 DBNL PTPRT CRMP1 ABHD17B TENM3 STAU2 PARD3 TNS1 CDH7 CDH12 PHLDB2 CDH18 | 2.30e-06 | 974 | 210 | 27 | GO:0034330 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | ITGA6 TENM2 PTK2B AP2A1 AGT COBL CCL19 HSPA5 PLXNA2 DNM2 FLNA NTRK2 DBNL PPP2R5D TENM3 STAU2 TMEM30A EP300 | 3.33e-06 | 494 | 210 | 18 | GO:0031346 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TUBA3E TOGARAM1 TUBA8 TUBA4A TUBA3C FSIP2 TUBA1B TUBA1A DNM2 CFAP47 FLNA CLIP2 TUBA3D TUBA1C RANBP9 CEP192 CEP70 CKAP2 PARD3 SPAG17 TTLL13 PHLDB2 | 4.67e-06 | 720 | 210 | 22 | GO:0000226 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CADM3 ABCA12 NEXMIF ITGA6 ITGA1 TENM2 CADM2 FAT2 GLI2 CNTN5 CCL19 NCK2 CDON MPZ FLNA DSC2 PCDHGB7 DSG1 PTPRT HMCN1 TENM3 EGFR DSG4 PARD3 CDH7 EP300 CDH12 CDH18 | 4.99e-06 | 1077 | 210 | 28 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | ITGA6 ADAM10 TENM2 PTK2B AP2A1 PTPRO AGT COBL CCL19 HSPA5 PLXNA2 DNM2 FLNA NTRK2 DBNL CRMP1 PPP2R5D ABHD17B TENM3 ATG3 STAU2 TMEM30A ULK2 EP300 | 5.96e-06 | 846 | 210 | 24 | GO:0120035 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | UNC5B ITGA1 ADAM10 TENM2 TUBA1A PTPRO GLI2 CNTN5 UGT8 COBL KDR PLXNA2 DNM2 NTRK2 DBNL LAMA2 NIBAN2 SEMA3D EGFR STAU2 PARD3 ULK2 EP300 | 7.93e-06 | 802 | 210 | 23 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | ITGA6 ADAM10 TENM2 PTK2B AP2A1 PTPRO AGT COBL CCL19 HSPA5 PLXNA2 DNM2 FLNA NTRK2 DBNL CRMP1 PPP2R5D ABHD17B TENM3 ATG3 STAU2 TMEM30A ULK2 EP300 | 8.32e-06 | 863 | 210 | 24 | GO:0031344 |
| GeneOntologyBiologicalProcess | cell-cell junction organization | F2R ADAM10 PTPRO AGT UGT8 MPZ FLNA DSG1 PARD3 CDH7 CDH12 CDH18 | 8.81e-06 | 246 | 210 | 12 | GO:0045216 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | UNC5B ITGA1 ADAM10 TENM2 TUBA1A PTPRO GLI2 CNTN5 UGT8 COBL KDR PLXNA2 DNM2 NTRK2 DBNL LAMA2 NIBAN2 SEMA3D EGFR STAU2 PARD3 ULK2 EP300 | 1.11e-05 | 819 | 210 | 23 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell morphogenesis | UNC5B ITGA1 ADAM10 TENM2 PTK2B TUBA1A PTPRO GLI2 NBEAL2 CNTN5 UGT8 COBL KDR PLXNA2 DNM2 FLNA NTRK2 DBNL LAMA2 NIBAN2 SEMA3D EGFR STAU2 PARD3 ULK2 CDH7 EP300 CDH12 CDH18 | 1.22e-05 | 1194 | 210 | 29 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | UNC5B ITGA1 ADAM10 TENM2 TUBA1A PTPRO GLI2 CNTN5 UGT8 COBL KDR PLXNA2 DNM2 NTRK2 DBNL LAMA2 NIBAN2 SEMA3D EGFR STAU2 PARD3 ULK2 EP300 | 1.27e-05 | 826 | 210 | 23 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | ITGA6 ADAM10 PTK2B AP2A1 PTPRO AGT COBL HSPA5 PLXNA2 FLNA NTRK2 DBNL CRMP1 PPP2R5D TENM3 STAU2 TMEM30A ULK2 EP300 | 1.73e-05 | 612 | 210 | 19 | GO:0010975 |
| GeneOntologyBiologicalProcess | cell junction assembly | ITGA6 PTK2B PTPRO CNTN5 AGT UGT8 KDR DSG1 NTRK2 DBNL CRMP1 STAU2 PARD3 TNS1 CDH7 CDH12 PHLDB2 CDH18 | 2.26e-05 | 569 | 210 | 18 | GO:0034329 |
| GeneOntologyBiologicalProcess | microtubule-based process | TUBA3E TOGARAM1 TUBA8 TUBA4A TUBA3C FSIP2 TUBA1B TUBA1A MAP3K11 DNM2 CFAP47 FLNA CLIP2 TUBA3D IFT81 TUBA1C RANBP9 CEP192 STAU2 CEP70 TMF1 CKAP2 PARD3 SPAG17 TTLL13 PHLDB2 | 2.95e-05 | 1058 | 210 | 26 | GO:0007017 |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 8.03e-05 | 217 | 210 | 10 | GO:0051897 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-glycine N-myristoylation | 1.03e-04 | 2 | 210 | 2 | GO:0018008 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | ITGA6 TOGARAM1 TENM2 FSIP2 PTPRO COBL CCL19 NCK2 DNM2 CFAP47 FLNA IFT81 GSN ATG3 BBS7 STAU2 CEP70 SPAG17 | 1.81e-04 | 670 | 210 | 18 | GO:0120031 |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 1.84e-04 | 52 | 210 | 5 | GO:0071526 | |
| GeneOntologyBiologicalProcess | axonogenesis | UNC5B TENM2 PTPRO GLI2 CNTN5 COBL PLXNA2 DNM2 NTRK2 DBNL LAMA2 NIBAN2 SEMA3D PARD3 ULK2 EP300 | 2.37e-04 | 566 | 210 | 16 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell projection assembly | ITGA6 TOGARAM1 TENM2 FSIP2 PTPRO COBL CCL19 NCK2 DNM2 CFAP47 FLNA IFT81 GSN ATG3 BBS7 STAU2 CEP70 SPAG17 | 2.37e-04 | 685 | 210 | 18 | GO:0030031 |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 2.82e-04 | 124 | 210 | 7 | GO:0007229 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure | 2.82e-04 | 124 | 210 | 7 | GO:0003073 | |
| GeneOntologyBiologicalProcess | vesicle scission | 3.07e-04 | 3 | 210 | 2 | GO:0099050 | |
| GeneOntologyBiologicalProcess | peptidyl-glycine modification | 3.07e-04 | 3 | 210 | 2 | GO:0018201 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | ITGA6 TOGARAM1 TENM2 PTK2B AP2A1 FCGR1BP AGT ELAPOR1 COBL KDR CCL19 DNM1 HSPA5 PLXNA2 NCK2 DNM2 FLNA NTRK2 DBNL GSN PPP2R5D TENM3 STAU2 TMEM30A PARD3 OGA EP300 PHLDB2 | 3.20e-04 | 1366 | 210 | 28 | GO:0051130 |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 3.21e-04 | 167 | 210 | 8 | GO:0007043 | |
| GeneOntologyBiologicalProcess | axon development | UNC5B TENM2 PTPRO GLI2 CNTN5 COBL PLXNA2 DNM2 FLNA NTRK2 DBNL LAMA2 NIBAN2 SEMA3D PARD3 ULK2 EP300 | 3.24e-04 | 642 | 210 | 17 | GO:0061564 |
| GeneOntologyCellularComponent | anchoring junction | CADM3 ITGA6 ITGA1 ADAM10 TENM2 LIN7B PTK2B FAT2 KDR FHL2 HSPA5 DNM2 FLNA DSC2 DSG1 DBNL NIBAN2 BCAR1 GSN KRIT1 SLC5A1 HMCN1 EGFR DSG4 PARD3 TNS1 CDH7 CDH12 PHLDB2 CDH18 | 6.70e-08 | 976 | 213 | 30 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell junction | CADM3 ITGA6 ADAM10 TENM2 LIN7B FAT2 FLNA DSC2 DSG1 NIBAN2 GSN KRIT1 SLC5A1 HMCN1 DSG4 PARD3 CDH7 CDH12 CDH18 | 1.08e-05 | 591 | 213 | 19 | GO:0005911 |
| GeneOntologyCellularComponent | adherens junction | ITGA6 ADAM10 LIN7B FAT2 DSC2 NIBAN2 HMCN1 PARD3 CDH7 CDH12 CDH18 | 1.19e-05 | 212 | 213 | 11 | GO:0005912 |
| GeneOntologyCellularComponent | microtubule | TUBA3E TOGARAM1 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A MAP3K11 DNM1 DNM2 CLIP2 TUBA3D TUBA1C STAU2 CKAP2 SPAG17 TTLL13 | 3.52e-05 | 533 | 213 | 17 | GO:0005874 |
| GeneOntologyCellularComponent | myelin sheath | 8.10e-05 | 217 | 213 | 10 | GO:0043209 | |
| GeneOntologyCellularComponent | cell-substrate junction | ITGA6 ITGA1 ADAM10 PTK2B FHL2 HSPA5 DNM2 FLNA BCAR1 GSN HMCN1 EGFR TNS1 PHLDB2 | 1.92e-04 | 443 | 213 | 14 | GO:0030055 |
| GeneOntologyCellularComponent | site of polarized growth | 2.82e-04 | 253 | 213 | 10 | GO:0030427 | |
| GeneOntologyCellularComponent | secretory granule | ABCA12 ITGA1 DCST2 TUBA8 ADAM10 F13A1 AP2A1 NBEAL2 MIF DLD DNM1 TREML1 KLK1 DSG1 CLIP2 DBNL GSN NAPRT LAMP3 TMEM30A SPAG17 CTSD PADI2 | 2.86e-04 | 1014 | 213 | 23 | GO:0030141 |
| GeneOntologyCellularComponent | somatodendritic compartment | AGO2 TMEM185A ITGA1 ADAM10 TENM2 CADM2 PTK2B PTPRO COBL KDR USH2A FUBP3 HSPA5 CNGA4 FLNA ADCY4 CLIP2 NTRK2 DBNL LAMA2 SRR CRMP1 ABHD17B STAU2 WDFY3 PARD3 | 3.32e-04 | 1228 | 213 | 26 | GO:0036477 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TUBA3E TOGARAM1 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A MAP3K11 COBL DNM1 DNM2 FLNA CLIP2 TUBA3D TUBA1C DBNL GSN STAU2 CKAP2 SPAG17 TTLL13 | 3.61e-04 | 899 | 213 | 21 | GO:0099513 |
| GeneOntologyCellularComponent | focal adhesion | ITGA6 ITGA1 ADAM10 PTK2B FHL2 HSPA5 DNM2 FLNA BCAR1 GSN EGFR TNS1 PHLDB2 | 5.04e-04 | 431 | 213 | 13 | GO:0005925 |
| GeneOntologyCellularComponent | lamellar body membrane | 6.12e-04 | 4 | 213 | 2 | GO:0097232 | |
| GeneOntologyCellularComponent | growth cone | 9.54e-04 | 245 | 213 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | supramolecular fiber | PPP1R12B TUBA3E TOGARAM1 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A MAP3K11 COBL DNM1 FHL2 DNM2 FLNA CLIP2 TUBA3D TUBA1C DBNL MYOM3 GSN STAU2 CKAP2 SPAG17 TTLL13 | 9.81e-04 | 1179 | 213 | 24 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | PPP1R12B TUBA3E TOGARAM1 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A MAP3K11 COBL DNM1 FHL2 DNM2 FLNA CLIP2 TUBA3D TUBA1C DBNL MYOM3 GSN STAU2 CKAP2 SPAG17 TTLL13 | 1.08e-03 | 1187 | 213 | 24 | GO:0099081 |
| GeneOntologyCellularComponent | lamellar body | 1.21e-03 | 21 | 213 | 3 | GO:0042599 | |
| GeneOntologyCellularComponent | Atg12-Atg5-Atg16 complex | 1.51e-03 | 6 | 213 | 2 | GO:0034274 | |
| Domain | Alpha_tubulin | 7.02e-13 | 9 | 209 | 7 | IPR002452 | |
| Domain | Tubulin_C | 2.94e-09 | 22 | 209 | 7 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 2.94e-09 | 22 | 209 | 7 | IPR018316 | |
| Domain | Tubulin_C | 2.94e-09 | 22 | 209 | 7 | SM00865 | |
| Domain | Tub_FtsZ_C | 4.18e-09 | 23 | 209 | 7 | IPR008280 | |
| Domain | Tubulin_C | 4.18e-09 | 23 | 209 | 7 | IPR023123 | |
| Domain | TUBULIN | 4.18e-09 | 23 | 209 | 7 | PS00227 | |
| Domain | Tubulin | 4.18e-09 | 23 | 209 | 7 | IPR000217 | |
| Domain | Tubulin | 4.18e-09 | 23 | 209 | 7 | SM00864 | |
| Domain | Tubulin_CS | 4.18e-09 | 23 | 209 | 7 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 5.85e-09 | 24 | 209 | 7 | IPR003008 | |
| Domain | Tubulin | 5.85e-09 | 24 | 209 | 7 | PF00091 | |
| Domain | - | 6.22e-08 | 20 | 209 | 6 | 3.30.1330.20 | |
| Domain | - | 8.62e-08 | 21 | 209 | 6 | 1.10.287.600 | |
| Domain | - | 1.17e-07 | 22 | 209 | 6 | 3.40.50.1440 | |
| Domain | Cadherin_C | 2.71e-07 | 25 | 209 | 6 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 2.71e-07 | 25 | 209 | 6 | IPR000233 | |
| Domain | Catenin_binding_dom | 7.00e-07 | 29 | 209 | 6 | IPR027397 | |
| Domain | - | 7.00e-07 | 29 | 209 | 6 | 4.10.900.10 | |
| Domain | Ig-like_fold | CADM3 UNC5B F13A1 CADM2 FCGR1BP PTPRO CNTN5 SIGLEC10 KDR USH2A TREML1 PLXNA2 CDON MPZ FLNA TRIM42 NTRK2 MYOM3 LEPR PTPRT SEMA3D HMCN1 TIE1 KIR3DL3 | 1.33e-06 | 706 | 209 | 24 | IPR013783 |
| Domain | - | CADM3 UNC5B F13A1 CADM2 FCGR1BP PTPRO CNTN5 SIGLEC10 KDR USH2A TREML1 PLXNA2 CDON MPZ FLNA TRIM42 NTRK2 MYOM3 LEPR PTPRT SEMA3D HMCN1 TIE1 | 1.59e-06 | 663 | 209 | 23 | 2.60.40.10 |
| Domain | BEACH | 1.84e-06 | 9 | 209 | 4 | PS50197 | |
| Domain | Beach | 1.84e-06 | 9 | 209 | 4 | PF02138 | |
| Domain | - | 1.84e-06 | 9 | 209 | 4 | 1.10.1540.10 | |
| Domain | Beach | 1.84e-06 | 9 | 209 | 4 | SM01026 | |
| Domain | BEACH_dom | 1.84e-06 | 9 | 209 | 4 | IPR000409 | |
| Domain | IG | CADM3 UNC5B CADM2 FCGR1BP CNTN5 SIGLEC10 KDR TREML1 CDON MPZ NTRK2 MYOM3 PTPRT SEMA3D HMCN1 TIE1 KIR3DL3 | 5.55e-06 | 421 | 209 | 17 | SM00409 |
| Domain | Ig_sub | CADM3 UNC5B CADM2 FCGR1BP CNTN5 SIGLEC10 KDR TREML1 CDON MPZ NTRK2 MYOM3 PTPRT SEMA3D HMCN1 TIE1 KIR3DL3 | 5.55e-06 | 421 | 209 | 17 | IPR003599 |
| Domain | DUF4704 | 1.36e-05 | 5 | 209 | 3 | IPR031570 | |
| Domain | DUF4704 | 1.36e-05 | 5 | 209 | 3 | PF15787 | |
| Domain | PH_BEACH | 2.69e-05 | 6 | 209 | 3 | PF14844 | |
| Domain | Cadherin_CS | 3.10e-05 | 109 | 209 | 8 | IPR020894 | |
| Domain | IG_LIKE | CADM3 UNC5B CADM2 FCGR1BP CNTN5 SIGLEC10 KDR TREML1 CDON MPZ NTRK2 MYOM3 LEPR PTPRT SEMA3D HMCN1 KIR3DL3 | 4.00e-05 | 491 | 209 | 17 | PS50835 |
| Domain | CADHERIN_1 | 4.03e-05 | 113 | 209 | 8 | PS00232 | |
| Domain | Cadherin | 4.03e-05 | 113 | 209 | 8 | PF00028 | |
| Domain | CADHERIN_2 | 4.29e-05 | 114 | 209 | 8 | PS50268 | |
| Domain | - | 4.29e-05 | 114 | 209 | 8 | 2.60.40.60 | |
| Domain | CA | 4.57e-05 | 115 | 209 | 8 | SM00112 | |
| Domain | Desmosomal_cadherin | 4.68e-05 | 7 | 209 | 3 | IPR009122 | |
| Domain | Cadherin-like | 4.86e-05 | 116 | 209 | 8 | IPR015919 | |
| Domain | Ig-like_dom | CADM3 UNC5B CADM2 FCGR1BP CNTN5 SIGLEC10 KDR TREML1 CDON MPZ NTRK2 MYOM3 LEPR PTPRT SEMA3D HMCN1 TIE1 | 5.39e-05 | 503 | 209 | 17 | IPR007110 |
| Domain | Cadherin | 5.49e-05 | 118 | 209 | 8 | IPR002126 | |
| Domain | Ig_I-set | 5.74e-05 | 190 | 209 | 10 | IPR013098 | |
| Domain | I-set | 5.74e-05 | 190 | 209 | 10 | PF07679 | |
| Domain | IGc2 | CADM3 UNC5B CADM2 FCGR1BP CNTN5 SIGLEC10 KDR CDON NTRK2 MYOM3 HMCN1 | 7.11e-05 | 235 | 209 | 11 | SM00408 |
| Domain | Ig_sub2 | CADM3 UNC5B CADM2 FCGR1BP CNTN5 SIGLEC10 KDR CDON NTRK2 MYOM3 HMCN1 | 7.11e-05 | 235 | 209 | 11 | IPR003598 |
| Domain | PH-BEACH_dom | 7.42e-05 | 8 | 209 | 3 | IPR023362 | |
| Domain | - | 7.42e-05 | 8 | 209 | 3 | 2.30.29.40 | |
| Domain | PH_BEACH | 7.42e-05 | 8 | 209 | 3 | PS51783 | |
| Domain | PH_dom-like | NBEAL1 PTK2B NBEAL2 MTMR3 DNM1 DNM2 RGPD5 RGPD8 NIBAN2 RGS3 ARHGAP12 WDFY3 TNS1 PHLDB2 PSD4 | 9.51e-05 | 426 | 209 | 15 | IPR011993 |
| Domain | Autophagy_act_C | 1.25e-04 | 2 | 209 | 2 | PF03987 | |
| Domain | Autophagy-rel_prot_3 | 1.25e-04 | 2 | 209 | 2 | IPR007135 | |
| Domain | NMT_1 | 1.25e-04 | 2 | 209 | 2 | PS00975 | |
| Domain | NMT_2 | 1.25e-04 | 2 | 209 | 2 | PS00976 | |
| Domain | NMT_C | 1.25e-04 | 2 | 209 | 2 | PF02799 | |
| Domain | NMT | 1.25e-04 | 2 | 209 | 2 | PF01233 | |
| Domain | MyristoylCoA_TrFase_C | 1.25e-04 | 2 | 209 | 2 | IPR022677 | |
| Domain | MyristoylCoA_TrFase_N | 1.25e-04 | 2 | 209 | 2 | IPR022676 | |
| Domain | MyristoylCoA_TrFase_CS | 1.25e-04 | 2 | 209 | 2 | IPR022678 | |
| Domain | MyristoylCoA_TrFase | 1.25e-04 | 2 | 209 | 2 | IPR000903 | |
| Domain | ConA-like_dom | NBEAL1 FAT2 NBEAL2 USH2A TRIM60 RANBP9 LAMA2 PTPRT EYS WDFY3 | 1.86e-04 | 219 | 209 | 10 | IPR013320 |
| Domain | FN3 | 2.44e-04 | 185 | 209 | 9 | SM00060 | |
| Domain | ig | 2.97e-04 | 190 | 209 | 9 | PF00047 | |
| Domain | Immunoglobulin | 2.97e-04 | 190 | 209 | 9 | IPR013151 | |
| Domain | Rhs_assc_core | 3.71e-04 | 3 | 209 | 2 | IPR022385 | |
| Domain | FN3 | 4.17e-04 | 199 | 209 | 9 | PS50853 | |
| Domain | Tyr_kinase_cat_dom | 4.62e-04 | 88 | 209 | 6 | IPR020635 | |
| Domain | TyrKc | 4.62e-04 | 88 | 209 | 6 | SM00219 | |
| Domain | fn3 | 4.87e-04 | 162 | 209 | 8 | PF00041 | |
| Domain | FN3_dom | 5.94e-04 | 209 | 209 | 9 | IPR003961 | |
| Domain | - | 6.95e-04 | 95 | 209 | 6 | 2.60.120.200 | |
| Domain | Tox-GHH_dom | 7.37e-04 | 4 | 209 | 2 | IPR028916 | |
| Domain | Desmoglein | 7.37e-04 | 4 | 209 | 2 | IPR009123 | |
| Domain | Tox-GHH | 7.37e-04 | 4 | 209 | 2 | PF15636 | |
| Domain | Ten_N | 7.37e-04 | 4 | 209 | 2 | IPR009471 | |
| Domain | Ten_N | 7.37e-04 | 4 | 209 | 2 | PF06484 | |
| Domain | TENEURIN_N | 7.37e-04 | 4 | 209 | 2 | PS51361 | |
| Domain | LAM_G_DOMAIN | 8.35e-04 | 38 | 209 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 1.02e-03 | 40 | 209 | 4 | PF02210 | |
| Domain | YD | 1.22e-03 | 5 | 209 | 2 | IPR006530 | |
| Domain | LamG | 1.46e-03 | 44 | 209 | 4 | SM00282 | |
| Domain | Dynamin_central | 1.81e-03 | 6 | 209 | 2 | IPR000375 | |
| Domain | GED | 1.81e-03 | 6 | 209 | 2 | SM00302 | |
| Domain | Dynamin_M | 1.81e-03 | 6 | 209 | 2 | PF01031 | |
| Domain | GED_dom | 1.81e-03 | 6 | 209 | 2 | IPR020850 | |
| Domain | GED | 1.81e-03 | 6 | 209 | 2 | PS51388 | |
| Domain | Dynamin_GTPase_CS | 1.81e-03 | 6 | 209 | 2 | IPR019762 | |
| Domain | GED | 1.81e-03 | 6 | 209 | 2 | PF02212 | |
| Domain | GED | 1.81e-03 | 6 | 209 | 2 | IPR003130 | |
| Domain | SH3_9 | 1.82e-03 | 78 | 209 | 5 | PF14604 | |
| Domain | Ig_V-set | 1.84e-03 | 199 | 209 | 8 | IPR013106 | |
| Domain | G_DYNAMIN_1 | 2.52e-03 | 7 | 209 | 2 | PS00410 | |
| Domain | DYNc | 2.52e-03 | 7 | 209 | 2 | SM00053 | |
| Domain | Pkinase_Tyr | 3.33e-03 | 129 | 209 | 6 | PF07714 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A CLIP2 TUBA3D TUBA1C | 7.27e-13 | 22 | 153 | 9 | M47903 |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B AP2A1 TUBA1A DNM1 DNM2 TUBA3D TUBA1C | 3.50e-12 | 49 | 153 | 11 | M891 |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.58e-12 | 17 | 153 | 8 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 6.39e-12 | 18 | 153 | 8 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.09e-11 | 19 | 153 | 8 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.09e-11 | 19 | 153 | 8 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 1.81e-11 | 20 | 153 | 8 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 1.81e-11 | 20 | 153 | 8 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 2.89e-11 | 21 | 153 | 8 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 2.89e-11 | 21 | 153 | 8 | M47767 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | TUBA3E ITGA1 TUBA8 TUBA4A TUBA3C TUBA1B AP2A1 TUBA1A DNM1 DNM2 TUBA3D TUBA1C RANBP9 EGFR | 4.82e-11 | 121 | 153 | 14 | M872 |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 6.84e-11 | 23 | 153 | 8 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 6.84e-11 | 23 | 153 | 8 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 6.84e-11 | 23 | 153 | 8 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.02e-10 | 24 | 153 | 8 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.02e-10 | 24 | 153 | 8 | M47700 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DNM1 DNM2 TUBA3D TUBA1C | 1.47e-10 | 51 | 153 | 10 | M26972 |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.48e-10 | 25 | 153 | 8 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.48e-10 | 25 | 153 | 8 | M47710 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | TUBA8 TUBA4A TUBA1B AP2A1 TUBA1A DNM1 DNM2 TUBA3D TUBA1C RANBP9 EGFR | 1.54e-10 | 68 | 153 | 11 | MM14968 |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.58e-10 | 37 | 153 | 9 | MM15102 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 2.12e-10 | 26 | 153 | 8 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.12e-10 | 26 | 153 | 8 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 4.14e-10 | 28 | 153 | 8 | M47898 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 5.67e-10 | 29 | 153 | 8 | M27948 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | TUBA3E TUBA8 TUBA4A TUBA3C LIN7B TUBA1B TUBA1A TUBA3D TUBA1C | 8.46e-10 | 44 | 153 | 9 | M27934 |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C TTLL13 | 1.29e-09 | 46 | 153 | 9 | M27828 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.35e-09 | 32 | 153 | 8 | M27491 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.35e-09 | 32 | 153 | 8 | M29848 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 1.77e-09 | 33 | 153 | 8 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 1.77e-09 | 33 | 153 | 8 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.94e-09 | 35 | 153 | 8 | M47774 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 5.95e-09 | 38 | 153 | 8 | M14981 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 6.85e-09 | 55 | 153 | 9 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 8.09e-09 | 56 | 153 | 9 | M2333 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.14e-08 | 27 | 153 | 7 | MM15549 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B AP2A1 TUBA1A DNM1 DNM2 TUBA3D TUBA1C CTSD | 1.16e-08 | 126 | 153 | 12 | M705 |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.66e-08 | 17 | 153 | 6 | MM14731 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 1.68e-08 | 43 | 153 | 8 | M47773 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.68e-08 | 43 | 153 | 8 | M47669 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.04e-08 | 44 | 153 | 8 | MM14606 | |
| Pathway | REACTOME_AGGREPHAGY | 2.04e-08 | 44 | 153 | 8 | M29830 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 2.46e-08 | 45 | 153 | 8 | M47670 | |
| Pathway | KEGG_GAP_JUNCTION | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A ADCY4 TUBA3D TUBA1C EGFR | 4.59e-08 | 90 | 153 | 10 | M4013 |
| Pathway | BIOCARTA_MTA3_PATHWAY | 5.06e-08 | 20 | 153 | 6 | MM1383 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A HSPA5 TUBA3D TUBA1C | 6.93e-08 | 71 | 153 | 9 | M39690 |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C CEP192 CEP70 | 7.75e-08 | 95 | 153 | 10 | M6729 |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 8.57e-08 | 96 | 153 | 10 | MM14592 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TARBP2 FLNA TUBA3D TUBA1C OAS3 ABCE1 | 8.88e-08 | 151 | 153 | 12 | M550 |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 9.39e-08 | 53 | 153 | 8 | M27651 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TARBP2 TUBA3D TUBA1C | 1.27e-07 | 76 | 153 | 9 | M48037 |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.69e-07 | 57 | 153 | 8 | M27251 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | UNC5B ETF1 TUBA3E ITGA1 TUBA8 ADAM10 TUBA4A TUBA3C TUBA1B AP2A1 TUBA1A DNM1 PLXNA2 NCK2 DNM2 MPZ TUBA3D TUBA1C RANBP9 LAMA2 CRMP1 EGFR | 2.57e-07 | 575 | 153 | 22 | M29853 |
| Pathway | REACTOME_CILIUM_ASSEMBLY | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A CNGA4 TUBA3D IFT81 TUBA1C CEP192 BBS7 CEP70 | 2.84e-07 | 201 | 153 | 13 | M27472 |
| Pathway | REACTOME_KINESINS | 2.90e-07 | 61 | 153 | 8 | M977 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 3.63e-07 | 27 | 153 | 6 | MM15674 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | TUBA8 TUBA4A TUBA1B AP2A1 TUBA1A DNM1 DNM2 TUBA3D TUBA1C CTSD | 5.15e-07 | 116 | 153 | 10 | MM14855 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 5.73e-07 | 29 | 153 | 6 | MM15219 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | TUBA3E TUBA8 TUBA4A TUBA3C LIN7B TUBA1B TUBA1A TUBA3D TUBA1C | 8.00e-07 | 94 | 153 | 9 | M2843 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | TUBA8 TUBA4A TUBA1B AP2A1 TUBA1A DNM1 PLXNA2 NCK2 DNM2 TUBA3D TUBA1C RANBP9 CRMP1 EGFR | 9.50e-07 | 261 | 153 | 14 | MM15676 |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | CADM3 AGO2 ITGA6 CADM2 PTK2B NCK2 FLNA PARD3 CDH7 CDH12 CDH18 | 9.72e-07 | 155 | 153 | 11 | M522 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.06e-06 | 32 | 153 | 6 | MM14730 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 1.07e-06 | 72 | 153 | 8 | M26954 | |
| Pathway | REACTOME_AUTOPHAGY | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A MTMR3 ATG10 TUBA3D TUBA1C ATG3 | 1.17e-06 | 158 | 153 | 11 | M27935 |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.19e-06 | 73 | 153 | 8 | MM15126 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.62e-06 | 76 | 153 | 8 | M27215 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.79e-06 | 54 | 153 | 7 | M27482 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | PPP1R12B TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C CEP192 CEP70 EP300 | 1.84e-06 | 200 | 153 | 12 | M864 |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 2.18e-06 | 79 | 153 | 8 | M27743 | |
| Pathway | REACTOME_AGGREPHAGY | 2.21e-06 | 36 | 153 | 6 | MM15669 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 5.03e-06 | 117 | 153 | 9 | M19248 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 5.85e-06 | 90 | 153 | 8 | M29841 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 5.85e-06 | 90 | 153 | 8 | MM14979 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 7.04e-06 | 66 | 153 | 7 | MM17074 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 8.10e-06 | 94 | 153 | 8 | MM14515 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | TUBA8 TUBA4A TUBA1B AP2A1 TUBA1A DNM1 PLXNA2 NCK2 CDON DNM2 DSC2 DSG1 TUBA3D TUBA1C RANBP9 CRMP1 EGFR DSG4 | 8.51e-06 | 502 | 153 | 18 | MM14537 |
| Pathway | REACTOME_INTERFERON_SIGNALING | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B FCGR1BP TUBA1A TARBP2 FLNA TUBA3D TUBA1C OAS3 ABCE1 | 8.67e-06 | 273 | 153 | 13 | M983 |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C PPP2R5D | 9.84e-06 | 127 | 153 | 9 | M27181 |
| Pathway | REACTOME_PROTEIN_FOLDING | 1.10e-05 | 98 | 153 | 8 | M776 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.25e-05 | 48 | 153 | 6 | MM15353 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 1.25e-05 | 48 | 153 | 6 | MM15069 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.28e-05 | 100 | 153 | 8 | M27650 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C CEP192 PPP2R5D CEP70 | 1.38e-05 | 204 | 153 | 11 | M4217 |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | TUBA3E TUBA8 TUBA4A TUBA3C LIN7B TUBA1B AP2A1 TUBA1A ADCY4 TUBA3D TUBA1C | 1.45e-05 | 205 | 153 | 11 | M752 |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.48e-05 | 102 | 153 | 8 | M27648 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | GALNT3 ADAM10 PTK2B AP2A1 PTPRO KDR DNM1 NCK2 DNM2 NTRK2 PRR5 RANBP9 LAMA2 BCAR1 PPP2R5D EGFR CTSD EP300 | 1.86e-05 | 532 | 153 | 18 | M27870 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 1.92e-05 | 138 | 153 | 9 | M29805 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 2.00e-05 | 52 | 153 | 6 | MM15211 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 2.00e-05 | 52 | 153 | 6 | MM14949 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A CNGA4 TUBA3D IFT81 TUBA1C CEP192 BBS7 CEP70 | 2.12e-05 | 297 | 153 | 13 | M27050 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C PPP2R5D | 2.16e-05 | 140 | 153 | 9 | M27550 |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | TUBA8 TUBA4A TUBA1B TUBA1A CNGA4 TUBA3D IFT81 TUBA1C CEP192 BBS7 CEP70 | 2.46e-05 | 217 | 153 | 11 | MM14708 |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | TUBA3E TUBA8 TUBA4A TUBA3C IGLV3-19 TUBA1B IGLV3-1 AP2A1 FCGR1BP TUBA1A SIGLEC10 DNM1 TREML1 HSPA5 DNM2 SH3RF1 TUBA3D TUBA1C PRR5 RNF213 UBE2O PPP2R5D CTSD | 2.93e-05 | 828 | 153 | 23 | M1058 |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 3.13e-05 | 113 | 153 | 8 | M27471 | |
| Pathway | REACTOME_KINESINS | 3.41e-05 | 57 | 153 | 6 | MM15714 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 3.63e-05 | 18 | 153 | 4 | M225 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 3.73e-05 | 150 | 153 | 9 | M27440 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 3.77e-05 | 58 | 153 | 6 | M11980 | |
| Pathway | REACTOME_HEMOSTASIS | ITGA6 TUBA3E ITGA1 TUBA8 F2R TUBA4A TUBA3C F13A1 AK3 IGLV3-19 TUBA1B IGLV3-1 TUBA1A MIF HSPA5 FLNA TUBA3D TUBA1C BCAR1 PPP2R5D | 4.55e-05 | 679 | 153 | 20 | M8395 |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 5.12e-05 | 121 | 153 | 8 | M39823 | |
| Pubmed | 1.61e-17 | 9 | 214 | 8 | 21167302 | ||
| Pubmed | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A HSPA5 TUBA3D TUBA1C | 4.95e-15 | 22 | 214 | 9 | 28117675 | |
| Pubmed | 5.06e-14 | 6 | 214 | 6 | 16327313 | ||
| Pubmed | 1.28e-13 | 19 | 214 | 8 | 15698476 | ||
| Pubmed | 1.28e-13 | 19 | 214 | 8 | 15691386 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 1.40e-12 | 8 | 214 | 6 | 16148047 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 4.53e-11 | 12 | 214 | 6 | 15331610 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 4.77e-11 | 22 | 214 | 7 | 23826228 | |
| Pubmed | 5.03e-11 | 6 | 214 | 5 | 3785200 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 5.03e-11 | 6 | 214 | 5 | 7651436 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 8.37e-11 | 13 | 214 | 6 | 10908577 | |
| Pubmed | 1.46e-10 | 14 | 214 | 6 | 12486001 | ||
| Pubmed | 1.75e-10 | 7 | 214 | 5 | 11146551 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ABCA2 AGO2 ETF1 WDR81 PHGDH AP2A1 ELAPOR1 DLD NMT1 UNC79 HSPA5 DNM2 FLNA TUBA3D TUBA1C NIBAN2 UPF1 CPT1A GSN EPG5 ABCE1 SPAG17 CTSD MVD | 2.40e-10 | 807 | 214 | 24 | 30575818 |
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 1.04e-09 | 9 | 214 | 5 | 11953448 | |
| Pubmed | 1.39e-09 | 4 | 214 | 4 | 18400243 | ||
| Pubmed | TUBA3E TUBA4A TUBA3C PHGDH AP2A1 TUBA1A MIF FHL2 NMT1 FUBP3 HSPA5 HSPA7 RGPD5 FLNA RGPD8 DSG1 TUBA1C MUC16 RNF213 HMCN1 ABCE1 RPA1 CPNE7 | 3.06e-09 | 844 | 214 | 23 | 25963833 | |
| Pubmed | 3.48e-09 | 22 | 214 | 6 | 15103018 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | TUBA3E TUBA8 TUBA4A TUBA3C PHGDH TUBA1B TUBA1A MIF DLD HSPA5 HSPA7 TUBA1C GSN RPA1 | 3.72e-09 | 288 | 214 | 14 | 31501420 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ETF1 EMSY PHGDH DDX46 WIZ DDX50 MIF DLD TAF6 NMT1 DNM2 FLNA DSG1 DBNL NIBAN2 UPF1 YEATS2 UBE2O ABCE1 STAU2 CKAP2 OGA RPA1 CPSF3 | 4.26e-09 | 934 | 214 | 24 | 33916271 |
| Pubmed | AGO2 ABCA12 PER1 WIZ ACAD11 SUPT4H1 SFXN2 TAF6 TAF10 TARBP2 DSC2 RANBP9 ADNP2 RNF213 OAS3 TRIM33 SNIP1 YEATS2 PWWP2B WDFY3 CSMD1 PARD3 SLC25A19 PADI2 EP300 PHLDB2 | 6.93e-09 | 1116 | 214 | 26 | 31753913 | |
| Pubmed | AGO2 ETF1 WDR81 TENM2 EMSY WIZ AP2A1 DNM1 UNC79 DNM2 RGPD8 CLIP2 NTRK2 RANBP9 UPF1 GSN CRMP1 UBE2O PPP2R5D WDFY3 PARD3 RPA1 TNS1 PHLDB2 | 7.67e-09 | 963 | 214 | 24 | 28671696 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | TUBA8 TUBA4A TUBA3C AP2A1 TUBA1A DNM1 HSPA5 HSPA7 FLNA TUBA1C RANBP9 RGS3 GSN RPA1 | 1.26e-08 | 317 | 214 | 14 | 17620599 |
| Pubmed | Endogenously nitrated proteins in mouse brain: links to neurodegenerative disease. | 1.34e-08 | 27 | 214 | 6 | 16800626 | |
| Pubmed | AGO2 PPP1R12B ITGA6 TUBA1B RFTN1 WIZ DDX50 MTMR3 HSPA5 NCK2 RBM15 RNF213 CEP192 NIBAN2 BCAR1 PTPRT PACS1 PPP2R5D EGFR TMF1 CKAP2 RPA1 TNS1 CPSF3 | 3.86e-08 | 1049 | 214 | 24 | 27880917 | |
| Pubmed | 4.81e-08 | 7 | 214 | 4 | 36681692 | ||
| Pubmed | 4.90e-08 | 17 | 214 | 5 | 17360745 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ETF1 PNO1 TUBA4A EMSY PTGR3 DDX46 AP2A1 DDX50 UTP15 TUBA1A DLD TAF6 TAF10 FUBP3 HSPA5 DNM2 FLNA RBM15 TUBA1C UPF1 NUBP2 SNIP1 YEATS2 ABCE1 STAU2 RPA1 CPSF3 | 4.97e-08 | 1318 | 214 | 27 | 30463901 |
| Pubmed | 9.06e-08 | 90 | 214 | 8 | 33087562 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ETF1 PNO1 TUBA4A TUBA1A DLD DNM1 FHL2 NMT1 FUBP3 HSPA5 PRUNE2 FLNA TUBA1C DBNL RANBP9 NIBAN2 BCAR1 NUBP2 CRMP1 ZNF503 UBE2O PPP2R5D ATG3 ABCE1 NAPRT OGA RPA1 MVD | 1.00e-07 | 1455 | 214 | 28 | 22863883 |
| Pubmed | 1.27e-07 | 94 | 214 | 8 | 36584595 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | PNO1 F13A1 PHGDH TUBA1B WIZ TUBA1A PTPRO SUPT4H1 NMT2 KDR DNM1 TARBP2 NCK2 DNM2 RBM15 RANBP9 UPF1 LEPR CRMP1 CEP70 OGA RPA1 TNS1 CPNE7 | 1.38e-07 | 1124 | 214 | 24 | 21900206 |
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 1.38e-07 | 95 | 214 | 8 | 27129302 | |
| Pubmed | PNO1 PHGDH DDX46 AP2A1 DDX50 SUPT4H1 NMT2 TAF6 FUBP3 HSPA5 DNM2 FLNA RBM15 UPF1 ATG3 ABCE1 CPSF3 EP300 | 1.46e-07 | 653 | 214 | 18 | 33742100 | |
| Pubmed | AGO2 TUBA1B TUBA1A COBL FUBP3 HSPA5 FLNA DSC2 TUBA1C UPF1 RPA1 CPSF3 | 1.54e-07 | 274 | 214 | 12 | 34244482 | |
| Pubmed | 1.71e-07 | 9 | 214 | 4 | 19103752 | ||
| Pubmed | GALNT3 PPP1R12B PNO1 GON4L EMSY PHGDH TUBA1B RFTN1 DDX46 WIZ ACAD11 DDX50 UTP15 NMT2 ELAPOR1 TAF6 TAF10 FHL2 NMT1 TARBP2 TUBA1C DBNL TRIM33 SNIP1 STAU2 TMF1 CKAP2 PARD3 | 1.79e-07 | 1497 | 214 | 28 | 31527615 | |
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 11163133 | ||
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 22371560 | ||
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 2.30e-07 | 3 | 214 | 3 | 9722999 | |
| Pubmed | NBEAL1 UNC5B DMXL1 WIZ MAP3K11 COBL NCK2 PRUNE2 PLBD2 PPP2R5D ABCE1 WDFY3 | 2.36e-07 | 285 | 214 | 12 | 34369648 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | AGO2 PNO1 TUBA8 TUBA4A TUBA1B AP2A1 DDX50 TUBA1A FUBP3 HSPA5 FLNA RBM15 TUBA1C PRR5 UPF1 GSN STAU2 CKAP2 | 2.53e-07 | 678 | 214 | 18 | 30209976 |
| Pubmed | AGO2 PPP1R12B ETF1 TUBA4A PHGDH CADM2 PTK2B AP2A1 FCGR1BP TUBA1A NMT2 DLD DNM1 HSPA5 NCK2 DNM2 FLNA ADCY4 CLIP2 TUBA1C DBNL UPF1 GSN CRMP1 PACS1 UBE2O TNS1 | 2.56e-07 | 1431 | 214 | 27 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | AGO2 PNO1 TUBA4A PHGDH AP2A1 DDX50 UTP15 MIF FHL2 FUBP3 HSPA5 FLNA RBM15 DSG1 DBNL RANBP9 ADNP2 OAS3 UPF1 ABCE1 WDFY3 PARD3 RPA1 CTSD CPSF3 PHLDB2 | 3.07e-07 | 1353 | 214 | 26 | 29467282 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ETF1 ITGA6 EMSY PHGDH DDX46 AP2A1 UTP15 DLD FHL2 NMT1 FUBP3 HSPA5 FLNA DSG1 RNF213 OAS3 NIBAN2 UPF1 PLBD2 GSN UBE2O ABCE1 STAU2 CPSF3 MVD PHLDB2 | 3.74e-07 | 1367 | 214 | 26 | 32687490 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | PHGDH TUBA1B DDX46 WIZ TUBA1A DCLRE1A HSPA5 FLNA DSG1 TRIM33 YEATS2 RPA1 CTSD | 3.88e-07 | 357 | 214 | 13 | 37059091 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 ABCA2 PER1 WIZ AP2A1 NBEAL2 MTMR3 NAV2 MAP3K11 COBL NCK2 FLNA ATG10 SH3RF1 MYOM3 CEP192 ZNF503 PWWP2B NAPRT KCNK5 WDFY3 ULK2 EP300 | 3.99e-07 | 1105 | 214 | 23 | 35748872 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | AGO2 UNC5B PPP1R12B TUBA4A TUBA3C TUBA1B TUBA1A HSPA5 HSPA7 DSG1 TUBA1C CEP192 PPP2R5D CEP70 EP300 PHLDB2 CPNE7 | 5.35e-07 | 639 | 214 | 17 | 23443559 |
| Pubmed | TUBA3E TUBA4A TUBA3C PHGDH TUBA1B AP2A1 TUBA1A MIF DLD HSPA5 HSPA7 FLNA RBM15 TUBA1C SRR NIBAN2 NUBP2 CRMP1 RPA1 MVD | 6.00e-07 | 878 | 214 | 20 | 37223481 | |
| Pubmed | 6.41e-07 | 50 | 214 | 6 | 23703321 | ||
| Pubmed | AGO2 PHGDH TUBA1B DDX46 DDX50 DLD TAF6 FHL2 HSPA5 TARBP2 FLNA DSG1 TUBA1C UPF1 CPT1A STAU2 RPA1 | 7.52e-07 | 655 | 214 | 17 | 35819319 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | TUBA4A PTK2B WIZ FCGR1BP TUBA1A UNC79 TARBP2 INTS6L DSG1 UPF1 RPA1 PHLDB2 | 8.32e-07 | 321 | 214 | 12 | 32098917 |
| Pubmed | AGO2 TUBA8 TUBA1B AP2A1 TUBA1A DNM1 HSPA5 HSPA7 DNM2 TUBA1C BCAR1 | 9.03e-07 | 266 | 214 | 11 | 19380743 | |
| Pubmed | Nephrocystin interacts with Pyk2, p130(Cas), and tensin and triggers phosphorylation of Pyk2. | 9.15e-07 | 4 | 214 | 3 | 11493697 | |
| Pubmed | EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. | 9.15e-07 | 4 | 214 | 3 | 23636329 | |
| Pubmed | 9.91e-07 | 215 | 214 | 10 | 35973513 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ETF1 PNO1 ITGA6 TUBA4A PHGDH TUBA1B AP2A1 DDX50 UTP15 FHL2 NMT1 HSPA5 FLNA RBM15 DSG1 TUBA1C OAS3 UPF1 GSN EGFR STAU2 CKAP2 CTSD PHLDB2 | 1.02e-06 | 1257 | 214 | 24 | 36526897 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | AGO2 TUBA4A TUBA3C PHGDH TUBA1B TUBA1A SFXN2 DLD FUBP3 HSPA5 DNM2 RGPD5 RBM15 RGPD8 DSG1 TUBA1C UPF1 CPT1A NUBP2 ABCE1 SLC25A19 OGA RPA1 CPSF3 | 1.02e-06 | 1257 | 214 | 24 | 37317656 |
| Pubmed | Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation. | 1.33e-06 | 14 | 214 | 4 | 20802490 | |
| Pubmed | ABCA2 TUBA1B WIZ AP2A1 NMT2 MTMR3 MAP3K11 TAF6 DNM1 HSPA5 DNM2 CLIP2 IFT81 RANBP9 ADNP2 CRMP1 KRIT1 TRIM33 UBE2O CEP70 WDFY3 CKAP2 PADI2 EP300 | 1.49e-06 | 1285 | 214 | 24 | 35914814 | |
| Pubmed | PNO1 ADAM10 TUBA4A PHGDH PM20D2 TUBA1B AP2A1 DDX50 MIF FHL2 HSPA5 DNM2 FLNA DBNL CPT1A PLBD2 PPP2R5D ABHD17B EGFR NAPRT TMEM30A RPA1 CTSD CPSF3 | 1.75e-06 | 1297 | 214 | 24 | 33545068 | |
| Pubmed | AGO2 EMSY PHGDH DDX46 WIZ TAF6 HSPA5 RGPD5 FLNA DBNL UPF1 YEATS2 UBE2O PARD3 EP300 | 1.84e-06 | 549 | 214 | 15 | 38280479 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | PPP1R12B PHGDH TUBA1B DDX46 AP2A1 DDX50 UTP15 TAF6 FHL2 HSPA5 HSPA7 FLNA RBM15 DSG1 UPF1 BCAR1 GSN SNIP1 RPA1 CPSF3 | 1.97e-06 | 949 | 214 | 20 | 36574265 |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 2.10e-06 | 182 | 214 | 9 | 30711629 | |
| Pubmed | Dynamin reduces Pyk2 Y402 phosphorylation and SRC binding in osteoclasts. | 2.28e-06 | 5 | 214 | 3 | 19380485 | |
| Pubmed | UNC5B ITGA6 RFTN1 AP2A1 COBL DSC2 PRR5 NIBAN2 PACS1 TENM3 EGFR PARD3 PHLDB2 | 2.43e-06 | 421 | 214 | 13 | 36976175 | |
| Pubmed | TUBA3E TUBA8 TUBA4A PHGDH TUBA1B DDX46 AP2A1 DDX50 TUBA1A MIF HSPA5 HSPA7 FLNA DSG1 TUBA1C RANBP9 CEP192 NUBP2 ZNF503 UBE2O STAU2 CPNE7 | 2.98e-06 | 1153 | 214 | 22 | 29845934 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | AGO2 PNO1 CWC25 TUBA4A PHGDH TUBA1B UTP15 AGT NAV2 FUBP3 TARBP2 DSC2 NUBP2 ABCE1 STAU2 CKAP2 RPA1 | 3.36e-06 | 732 | 214 | 17 | 34732716 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | TUBA4A PHGDH TUBA1B RFTN1 AP2A1 TUBA1A DLD HSPA5 FLNA OAS3 UPF1 CPT1A GSN EGFR TNS1 | 3.58e-06 | 580 | 214 | 15 | 35676659 |
| Pubmed | ABCA2 ABCA12 TUBA3E TUBA8 TUBA4A TUBA3C EMSY TUBA1B DDX50 TUBA1A UGT8 RGPD8 DSG4 SPAG17 | 4.14e-06 | 513 | 214 | 14 | 25798074 | |
| Pubmed | 4.21e-06 | 312 | 214 | 11 | 37120454 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | TUBA3C EMSY DDX50 TAF6 HSPA5 FLNA TUBA1C NIBAN2 UPF1 TRIM33 YEATS2 STAU2 RPA1 | 4.32e-06 | 444 | 214 | 13 | 34795231 |
| Pubmed | 4.53e-06 | 6 | 214 | 3 | 18613978 | ||
| Pubmed | 4.53e-06 | 6 | 214 | 3 | 12090300 | ||
| Pubmed | 4.53e-06 | 6 | 214 | 3 | 10840040 | ||
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | AGO2 ETF1 TUBA4A TUBA3C DDX50 FUBP3 TUBA1C UPF1 STAU2 CPSF3 PHLDB2 | 4.61e-06 | 315 | 214 | 11 | 26777405 |
| Pubmed | 4.89e-06 | 257 | 214 | 10 | 16335952 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ITGA1 PHGDH WIZ TUBA1A PTPRO MIF KLK1 HSPA5 DNM2 FLNA DSC2 DBNL NIBAN2 GSN SLC5A1 EYS NAPRT CTSD PADI2 ENPEP | 5.45e-06 | 1016 | 214 | 20 | 19056867 |
| Pubmed | TUBA4A TUBA1B TUBA1A DNM1 HSPA5 FLNA CLIP2 TUBA1C COX11 CRMP1 TENM3 | 5.68e-06 | 322 | 214 | 11 | 26514267 | |
| Pubmed | AGO2 PNO1 TUBA4A MIF ELAPOR1 COBL HSPA5 FLNA UPF1 CPT1A CRMP1 TMEM30A TNS1 | 6.94e-06 | 464 | 214 | 13 | 32457219 | |
| Pubmed | ADAM10 PHGDH TUBA1B TUBA1A UGT8 HSPA5 DNM2 TUBA1C CPT1A PLBD2 LEPR EGFR ABCE1 RPA1 CTSD | 6.94e-06 | 613 | 214 | 15 | 22268729 | |
| Pubmed | 7.30e-06 | 212 | 214 | 9 | 23463506 | ||
| Pubmed | DMXL1 WIZ DDX50 DCLRE1A CDON DSC2 TUBA1C MUC16 RNF213 CEP192 KBTBD2 TRIM33 TENM3 EGFR TMF1 PARD3 SLC25A19 | 7.34e-06 | 777 | 214 | 17 | 35844135 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ETF1 PNO1 TUBA4A PHGDH TUBA1B DDX46 AP2A1 TUBA1A MIF FHL2 NMT1 HSPA5 FLNA DSG1 TUBA1C RANBP9 UPF1 CPT1A NUBP2 GSN UBE2O PPP2R5D EGFR CTSD | 7.64e-06 | 1415 | 214 | 24 | 28515276 |
| Pubmed | 7.68e-06 | 21 | 214 | 4 | 36332009 | ||
| Pubmed | 7.73e-06 | 76 | 214 | 6 | 27542412 | ||
| Pubmed | 7.91e-06 | 162 | 214 | 8 | 25826454 | ||
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | 8.00e-06 | 116 | 214 | 7 | 22810585 | |
| Pubmed | 8.04e-06 | 272 | 214 | 10 | 31010829 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | TUBA8 PHGDH TUBA1B PTK2B AP2A1 TUBA1A DLD DNM1 FHL2 HSPA5 DNM2 BCAR1 GSN CRMP1 PARD3 | 8.09e-06 | 621 | 214 | 15 | 22794259 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HIVEP1 ZNF280D ETF1 PHGDH TUBA1B AP2A1 DDX50 UTP15 MIF DLD FUBP3 HSPA5 FLNA RBM15 ADCY4 DSG1 TUBA1C DBNL UPF1 UBE2O ABCE1 RPA1 CTSD CPSF3 | 8.59e-06 | 1425 | 214 | 24 | 30948266 |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | ETF1 CWC25 TUBA4A PHGDH PM20D2 TUBA1B TUBA1A DLD FUBP3 HSPA5 TARBP2 TUBA1C DBNL STAU2 TMEM30A CTSD | 8.60e-06 | 704 | 214 | 16 | 32994395 |
| Pubmed | UNC5B ETF1 PHGDH HSPA5 NCK2 SH3RF1 DSC2 NIBAN2 UPF1 PPP2R5D EGFR ABCE1 ARHGAP12 PARD3 SLC25A19 RPA1 | 9.22e-06 | 708 | 214 | 16 | 39231216 | |
| Pubmed | 9.35e-06 | 22 | 214 | 4 | 35245678 | ||
| Pubmed | TUBA4A DDX46 AP2A1 COBL FUBP3 HSPA5 FLNA RBM15 TUBA1C EGFR RPA1 | 9.47e-06 | 340 | 214 | 11 | 24332808 | |
| Pubmed | Phospho-tyrosine dependent protein-protein interaction network. | CYP2C8 GALNT3 PPP1R12B PER1 WIZ TARBP2 NCK2 TUBA1C KRIT1 WDFY3 TNS1 KRTCAP2 | 1.02e-05 | 410 | 214 | 12 | 25814554 |
| Pubmed | ETF1 TUBA3E TUBA1B AP2A1 TUBA1A MIF FLNA TUBA1C BCAR1 NUBP2 TMEM30A CPSF3 | 1.04e-05 | 411 | 214 | 12 | 36652389 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | WDR81 PNO1 CWC25 F13A1 SFXN2 COBL CEP192 NIBAN2 UPF1 NUBP2 ABHD17B TENM3 EGFR STAU2 TMF1 PARD3 | 1.12e-05 | 719 | 214 | 16 | 35337019 |
| Pubmed | HIVEP1 NAV2 MAP3K11 COBL HSPA5 INTS6L FLNA SH3RF1 CLIP2 RANBP9 ADNP2 TNS1 EP300 | 1.13e-05 | 486 | 214 | 13 | 20936779 | |
| Interaction | TCP11L2 interactions | 1.20e-09 | 21 | 209 | 7 | int:TCP11L2 | |
| Interaction | GRM7 interactions | 2.81e-08 | 19 | 209 | 6 | int:GRM7 | |
| Interaction | ITGAD interactions | 4.43e-07 | 46 | 209 | 7 | int:ITGAD | |
| Interaction | YWHAZ interactions | HIVEP1 AGO2 TUBA3C FSIP2 TUBA1A PTPRO NBEAL2 MTMR3 NAV2 MAP3K11 DLD HSPA5 RBM15 SH3RF1 DSC2 CLIP2 PRR5 CEP192 BCAR1 RGS3 GSN PACS1 EGFR KCNK5 WDFY3 PARD3 RPA1 CTSD PADI2 TNS1 EP300 PHLDB2 PSD4 | 2.21e-06 | 1319 | 209 | 33 | int:YWHAZ |
| Interaction | MCM2 interactions | TUBA3E TUBA4A TUBA3C PHGDH AP2A1 TUBA1A MIF FHL2 NMT1 FUBP3 HSPA5 HSPA7 RGPD5 FLNA RGPD8 DSG1 TUBA1C DBNL MUC16 RNF213 OAS3 TRIM33 UBE2O HMCN1 EGFR ABCE1 RPA1 EP300 CPNE7 | 2.56e-06 | 1081 | 209 | 29 | int:MCM2 |
| Interaction | NCKAP1 interactions | ETF1 ADAM10 AP2A1 DNM1 HSPA5 NCK2 FLNA ADNP2 CRMP1 EGFR ARHGAP12 RPA1 | 3.08e-06 | 218 | 209 | 12 | int:NCKAP1 |
| Interaction | JUP interactions | PHGDH DLD FHL2 HSPA5 FLNA DSC2 DSG1 RANBP9 BCAR1 TRIM33 SNIP1 UBE2O EGFR ABCE1 PARD3 OGA RPA1 EP300 | 3.31e-06 | 485 | 209 | 18 | int:JUP |
| Interaction | ATG9A interactions | NBEAL1 UNC5B DMXL1 WIZ AP2A1 MAP3K11 COBL NCK2 PRUNE2 ATG10 TRIM42 PLBD2 RGS3 PPP2R5D ATG3 ABCE1 WDFY3 | 4.28e-06 | 445 | 209 | 17 | int:ATG9A |
| Interaction | ZC2HC1A interactions | 4.39e-06 | 64 | 209 | 7 | int:ZC2HC1A | |
| Interaction | AGR2 interactions | ABCA2 AGO2 ETF1 WDR81 PHGDH AP2A1 ELAPOR1 DLD NMT1 UNC79 HSPA5 DNM2 FLNA TUBA3D TUBA1C NIBAN2 UPF1 CPT1A GSN CRMP1 EPG5 ABCE1 CKAP2 SPAG17 CTSD MVD | 4.61e-06 | 934 | 209 | 26 | int:AGR2 |
| Interaction | TTC5 interactions | 4.88e-06 | 65 | 209 | 7 | int:TTC5 | |
| Interaction | SIGLEC10 interactions | 5.21e-06 | 12 | 209 | 4 | int:SIGLEC10 | |
| Interaction | LYN interactions | UNC5B TMEM185A PTK2B RFTN1 NMT1 FUBP3 PRUNE2 SH3RF1 DSC2 DSG1 NIBAN2 BCAR1 CPT1A PACS1 EGFR ABCE1 ARHGAP12 DENND2C LAMP3 PARD3 RPA1 PHLDB2 | 6.22e-06 | 720 | 209 | 22 | int:LYN |
| Interaction | PTPN11 interactions | ADAM10 PTK2B FCGR1BP KDR TREML1 HSPA5 DNM2 NTRK2 BCAR1 LEPR TRIM33 TIE1 EGFR OGA RPA1 | 7.40e-06 | 368 | 209 | 15 | int:PTPN11 |
| Interaction | LTA interactions | 9.25e-06 | 28 | 209 | 5 | int:LTA | |
| Interaction | BSG interactions | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B AP2A1 TUBA1A NBEAL2 SFXN2 DNM1 FUBP3 HSPA5 DNM2 FLNA TUBA3D TUBA1C RNF213 LAMP3 WDFY3 RPA1 | 9.89e-06 | 631 | 209 | 20 | int:BSG |
| Interaction | PXN interactions | ITGA6 TUBA8 ADAM10 TUBA3C TUBA1B PTK2B PTPRO HSPA5 HSPA7 NCK2 SH3RF1 CEP192 BCAR1 GSN | 1.10e-05 | 334 | 209 | 14 | int:PXN |
| Interaction | HDAC6 interactions | TUBA8 TUBA4A PHGDH TUBA1B RFTN1 AP2A1 UTP15 TUBA1A GLI2 NAV2 DLD HSPA5 FLNA TUBA1C RANBP9 OAS3 UPF1 CPT1A GSN TRIM33 EGFR CEP70 RPA1 TNS1 EP300 | 1.27e-05 | 929 | 209 | 25 | int:HDAC6 |
| Interaction | ATP8A1 interactions | 1.32e-05 | 30 | 209 | 5 | int:ATP8A1 | |
| Interaction | NR4A1 interactions | AGO2 PHGDH TUBA1B ACAD11 TUBA1A FUBP3 HSPA5 UPF1 CPT1A STAU2 EP300 | 1.39e-05 | 212 | 209 | 11 | int:NR4A1 |
| Interaction | RAC1 interactions | UNC5B ETF1 ITGA6 ITGA1 TUBA4A TUBA1B DDX50 TUBA1A MAP3K11 COBL FLNA RBM15 SH3RF1 DSC2 PRR5 NIBAN2 BCAR1 CPT1A KRIT1 PACS1 EGFR ABCE1 ARHGAP12 DSG4 PARD3 RPA1 PHLDB2 | 1.57e-05 | 1063 | 209 | 27 | int:RAC1 |
| Interaction | CD81 interactions | ITGA6 TUBA3E ITGA1 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A FLNA TUBA3D TUBA1C EGFR RPA1 | 1.78e-05 | 303 | 209 | 13 | int:CD81 |
| Interaction | ARRB1 interactions | TUBA4A TUBA3C AP2A1 DNM1 HSPA5 HSPA7 FLNA TUBA1C RANBP9 RGS3 GSN EGFR EP300 | 1.84e-05 | 304 | 209 | 13 | int:ARRB1 |
| Interaction | SRC interactions | TMEM185A TUBA4A TUBA1B PTK2B KDR DNM1 NMT1 HSPA5 DNM2 PRUNE2 FLNA RANBP9 BCAR1 GSN CRMP1 EGFR ABCE1 LAMP3 RPA1 EP300 | 2.06e-05 | 664 | 209 | 20 | int:SRC |
| Interaction | ABI1 interactions | TUBA1B FHL2 HSPA7 NCK2 DNM2 RBM15 NTRK2 BCAR1 EGFR ARHGAP12 RPA1 | 2.23e-05 | 223 | 209 | 11 | int:ABI1 |
| Interaction | WASF3 interactions | 2.70e-05 | 57 | 209 | 6 | int:WASF3 | |
| Interaction | VAV1 interactions | TUBA3E TUBA4A TUBA3C TUBA1B PTK2B TUBA1A GLI2 NCK2 DNM2 DSG1 EGFR | 2.74e-05 | 228 | 209 | 11 | int:VAV1 |
| Interaction | PAK1 interactions | TUBA3E TUBA3C TUBA1B TUBA1A HSPA7 NCK2 FLNA TUBA1C CPT1A GSN EGFR | 2.85e-05 | 229 | 209 | 11 | int:PAK1 |
| Interaction | SLX4 interactions | EMSY PHGDH TUBA1B DDX46 WIZ ACAD11 AP2A1 TUBA1A DCLRE1A HSPA5 FLNA RBM15 DSG1 BCAR1 TRIM33 YEATS2 RPA1 CTSD | 3.08e-05 | 572 | 209 | 18 | int:SLX4 |
| Interaction | ITLN1 interactions | 4.00e-05 | 61 | 209 | 6 | int:ITLN1 | |
| Interaction | BUD23 interactions | 4.39e-05 | 62 | 209 | 6 | int:BUD23 | |
| Interaction | RICTOR interactions | PHGDH TUBA1B DDX46 WIZ AP2A1 TUBA1A DLD HSPA5 RGPD5 FLNA RGPD8 DSG1 PRR5 UPF1 CPT1A GSN EGFR OGA RPA1 CTSD EP300 | 4.42e-05 | 759 | 209 | 21 | int:RICTOR |
| Interaction | TUBG1 interactions | UNC5B TUBA4A TUBA3C TUBA1B WIZ TUBA1A HSPA5 HSPA7 DSG1 TUBA1C CPT1A TRIM33 EGFR RPA1 | 4.82e-05 | 382 | 209 | 14 | int:TUBG1 |
| Interaction | DTNA interactions | 4.87e-05 | 125 | 209 | 8 | int:DTNA | |
| Interaction | TOP3B interactions | VWA5B2 ABCA2 AGO2 PER1 PHGDH WIZ AP2A1 NBEAL2 MTMR3 NAV2 MAP3K11 COBL NMT1 FUBP3 HSPA5 NCK2 FLNA RBM15 ATG10 SH3RF1 MYOM3 CEP192 UPF1 ZNF503 PWWP2B NAPRT KCNK5 WDFY3 OGA RPA1 ULK2 EP300 | 5.22e-05 | 1470 | 209 | 32 | int:TOP3B |
| Interaction | MKRN2 interactions | AGO2 ITGA6 GLI2 FUBP3 CEP192 UPF1 SEMA3D UBE2O TENM3 EGFR STAU2 TMEM30A PARD3 EP300 | 5.24e-05 | 385 | 209 | 14 | int:MKRN2 |
| Interaction | LLGL1 interactions | 5.52e-05 | 164 | 209 | 9 | int:LLGL1 | |
| Interaction | NXF2 interactions | 5.75e-05 | 65 | 209 | 6 | int:NXF2 | |
| Interaction | EPHA2 interactions | UNC5B TMEM185A ITGA6 TUBA1B RFTN1 AP2A1 PTPRO COBL NCK2 DSC2 NTRK2 PRR5 NIBAN2 PACS1 TENM3 EGFR LAMP3 PARD3 RPA1 PHLDB2 | 6.28e-05 | 719 | 209 | 20 | int:EPHA2 |
| Interaction | CAP1 interactions | 6.30e-05 | 207 | 209 | 10 | int:CAP1 | |
| Interaction | ASAP1 interactions | 7.27e-05 | 98 | 209 | 7 | int:ASAP1 | |
| Interaction | SNX1 interactions | 7.69e-05 | 212 | 209 | 10 | int:SNX1 | |
| Interaction | TXNIP interactions | 7.69e-05 | 212 | 209 | 10 | int:TXNIP | |
| Interaction | SH3D19 interactions | 8.06e-05 | 69 | 209 | 6 | int:SH3D19 | |
| Interaction | NAA40 interactions | ETF1 EMSY PHGDH DDX46 WIZ DDX50 MIF DLD TAF6 NMT1 DNM2 FLNA DSG1 DBNL NIBAN2 UPF1 YEATS2 UBE2O ABCE1 STAU2 CKAP2 OGA RPA1 CPSF3 | 8.26e-05 | 978 | 209 | 24 | int:NAA40 |
| Interaction | DYRK2 interactions | 8.35e-05 | 173 | 209 | 9 | int:DYRK2 | |
| Interaction | VCL interactions | ADAM10 TUBA1A KDR HSPA5 CEP192 BCAR1 NUBP2 GSN CRMP1 TRIM33 EGFR RPA1 | 8.63e-05 | 305 | 209 | 12 | int:VCL |
| Interaction | SLC7A5 interactions | 8.64e-05 | 215 | 209 | 10 | int:SLC7A5 | |
| Interaction | BAG2 interactions | VWA5B2 C3orf38 WIZ TUBA1A DLD HSPA5 TUBA1C DBNL ZNF503 TRIM33 YEATS2 PPP2R5D EGFR TMF1 CKAP2 RPA1 CPSF3 EP300 | 9.02e-05 | 622 | 209 | 18 | int:BAG2 |
| Interaction | TNRC6C interactions | 9.80e-05 | 138 | 209 | 8 | int:TNRC6C | |
| Interaction | CBL interactions | ITGA6 TUBA4A PTK2B TUBA1A MAP3K11 KDR HSPA5 NCK2 FLNA TUBA1C DBNL BCAR1 CRMP1 EGFR RPA1 EP300 | 1.02e-04 | 516 | 209 | 16 | int:CBL |
| Interaction | GRB2 interactions | ITGA6 ADAM10 PTK2B AP2A1 AGT KDR DNM1 HSPA5 RNF208 DNM2 FLNA ATG10 NTRK2 TUBA1C BCAR1 EGFR ATG3 ARHGAP12 WDFY3 RPA1 EP300 | 1.03e-04 | 806 | 209 | 21 | int:GRB2 |
| Interaction | CNTN5 interactions | 1.07e-04 | 2 | 209 | 2 | int:CNTN5 | |
| Interaction | HEY1 interactions | 1.08e-04 | 140 | 209 | 8 | int:HEY1 | |
| Interaction | PRSS50 interactions | 1.11e-04 | 46 | 209 | 5 | int:PRSS50 | |
| Interaction | HYOU1 interactions | ETF1 TUBA1A PTPRO DLD HSPA5 PLXNA2 FLNA BCAR1 TRIM33 TENM3 EGFR RPA1 | 1.24e-04 | 317 | 209 | 12 | int:HYOU1 |
| Interaction | STRAP interactions | 1.25e-04 | 270 | 209 | 11 | int:STRAP | |
| Interaction | FBL interactions | AGO2 PNO1 TUBA3C WIZ DDX50 UTP15 DLD NMT1 FUBP3 ATG10 UPF1 UBE2O EGFR ATG3 ABCE1 STAU2 CKAP2 RPA1 | 1.26e-04 | 639 | 209 | 18 | int:FBL |
| Interaction | NEK4 interactions | ABCA2 ABCA12 TUBA3E TUBA8 TUBA4A TUBA3C EMSY TUBA1B DDX50 TUBA1A MTMR3 UGT8 KLK1 RGPD8 LAMP3 DSG4 SPAG17 | 1.27e-04 | 582 | 209 | 17 | int:NEK4 |
| Interaction | GLDC interactions | AGO2 TUBA1B TUBA1A COBL FUBP3 HSPA5 FLNA DSC2 TUBA1C UPF1 RPA1 CPSF3 | 1.40e-04 | 321 | 209 | 12 | int:GLDC |
| Interaction | KLK5 interactions | 1.42e-04 | 109 | 209 | 7 | int:KLK5 | |
| Interaction | MLST8 interactions | 1.42e-04 | 109 | 209 | 7 | int:MLST8 | |
| Interaction | TSN interactions | 1.51e-04 | 110 | 209 | 7 | int:TSN | |
| Interaction | UTP15 interactions | 1.51e-04 | 110 | 209 | 7 | int:UTP15 | |
| Interaction | SOX2 interactions | HIVEP1 AGO2 PNO1 CWC25 TUBA4A PHGDH TUBA1B WIZ DDX50 UTP15 TUBA1A AGT NAV2 FUBP3 HSPA5 TARBP2 FLNA RBM15 DSC2 RANBP9 UPF1 NUBP2 TRIM33 PPP2R5D EGFR ABCE1 STAU2 CKAP2 RPA1 EP300 | 1.60e-04 | 1422 | 209 | 30 | int:SOX2 |
| Interaction | SERPINB11 interactions | 1.71e-04 | 11 | 209 | 3 | int:SERPINB11 | |
| Interaction | FBXO6 interactions | ABCA2 ITGA6 ADAM10 PHGDH TUBA1B TUBA1A UGT8 HSPA5 DNM2 DSG1 TUBA1C CPT1A PLBD2 LEPR EGFR ABCE1 LAMP3 RPA1 CTSD | 1.80e-04 | 717 | 209 | 19 | int:FBXO6 |
| Interaction | YAP1 interactions | TUBA3E TUBA8 TUBA4A TUBA3C PHGDH TUBA1B DDX46 TUBA1A MIF DLD TAF6 HSPA5 HSPA7 FLNA TUBA1C DBNL UPF1 NUBP2 GSN UBE2O EGFR PARD3 RPA1 EP300 MVD | 1.81e-04 | 1095 | 209 | 25 | int:YAP1 |
| Interaction | ATOH1 interactions | 1.84e-04 | 80 | 209 | 6 | int:ATOH1 | |
| Interaction | PIK3C3 interactions | 1.88e-04 | 114 | 209 | 7 | int:PIK3C3 | |
| Interaction | ZC2HC1B interactions | 1.89e-04 | 28 | 209 | 4 | int:ZC2HC1B | |
| Interaction | PLS3 interactions | 1.92e-04 | 237 | 209 | 10 | int:PLS3 | |
| Interaction | TFCP2 interactions | TUBA3E TUBA8 TUBA4A TUBA3C PHGDH TUBA1B TUBA1A MIF DLD HSPA5 HSPA7 TUBA1C GSN RPA1 | 1.94e-04 | 436 | 209 | 14 | int:TFCP2 |
| Interaction | AFDN interactions | HSPA5 NCK2 MRAS DSC2 NTRK2 CEP192 NIBAN2 EGFR TMF1 PARD3 RPA1 PHLDB2 | 1.96e-04 | 333 | 209 | 12 | int:AFDN |
| Interaction | MED18 interactions | 1.97e-04 | 81 | 209 | 6 | int:MED18 | |
| Interaction | ATP6V1B2 interactions | 1.98e-04 | 238 | 209 | 10 | int:ATP6V1B2 | |
| Interaction | HLA-B interactions | ABCA2 TUBA4A TUBA1A PTPRO HSPA5 RNF213 EGFR KIR3DL3 TMEM30A WDFY3 | 2.05e-04 | 239 | 209 | 10 | int:HLA-B |
| Interaction | BACE2 interactions | 2.11e-04 | 82 | 209 | 6 | int:BACE2 | |
| Interaction | ATXN7L3 interactions | 2.19e-04 | 53 | 209 | 5 | int:ATXN7L3 | |
| Interaction | AHI1 interactions | 2.25e-04 | 83 | 209 | 6 | int:AHI1 | |
| Interaction | EPN1 interactions | 2.33e-04 | 118 | 209 | 7 | int:EPN1 | |
| Interaction | NCK1 interactions | 2.42e-04 | 244 | 209 | 10 | int:NCK1 | |
| Interaction | PTK2B interactions | 2.45e-04 | 119 | 209 | 7 | int:PTK2B | |
| Interaction | TAF6 interactions | 2.50e-04 | 245 | 209 | 10 | int:TAF6 | |
| Interaction | RIOK1 interactions | AGO2 PNO1 TUBA4A PHGDH WIZ DDX50 TUBA1A HSPA5 FLNA UPF1 BCAR1 UBE2O EGFR STAU2 RPA1 EP300 | 2.68e-04 | 562 | 209 | 16 | int:RIOK1 |
| Interaction | SKI interactions | 2.71e-04 | 160 | 209 | 8 | int:SKI | |
| Interaction | RPS27 interactions | PNO1 TUBA4A FSIP2 TUBA1A HSPA5 RANBP9 UBE2O PPP2R5D EGFR ATG3 ABCE1 RPA1 | 2.78e-04 | 346 | 209 | 12 | int:RPS27 |
| Interaction | MYO6 interactions | AP2A1 TAF6 NMT1 HSPA5 FLNA NTRK2 CEP192 GSN YEATS2 UBE2O ABCE1 RPA1 PHLDB2 | 2.78e-04 | 398 | 209 | 13 | int:MYO6 |
| Interaction | ITGB1 interactions | ITGA6 ITGA1 PTK2B TUBA1A PTPRO KDR FHL2 HSPA5 FLNA RANBP9 EGFR LAMP3 RPA1 | 2.92e-04 | 400 | 209 | 13 | int:ITGB1 |
| Interaction | YY1 interactions | HIVEP1 AGO2 GON4L EMSY WIZ TAF6 FHL2 HSPA5 ADSS1 TRIM42 SNIP1 YEATS2 RPA1 EP300 | 2.93e-04 | 454 | 209 | 14 | int:YY1 |
| Interaction | IGBP1 interactions | 2.95e-04 | 162 | 209 | 8 | int:IGBP1 | |
| Interaction | PLK1 interactions | TUBA4A TUBA1A MTMR3 TARBP2 DNM2 DSG1 UPF1 BCAR1 TRIM33 UBE2O PPP2R5D EGFR TMF1 PARD3 RPA1 | 2.96e-04 | 510 | 209 | 15 | int:PLK1 |
| Interaction | KCNA3 interactions | UNC5B ETF1 PHGDH COBL DNM1 HSPA5 NCK2 SH3RF1 DSC2 NTRK2 RNF213 NIBAN2 UPF1 YEATS2 PPP2R5D EGFR ABCE1 ARHGAP12 PARD3 SLC25A19 RPA1 | 2.97e-04 | 871 | 209 | 21 | int:KCNA3 |
| Interaction | RHOA interactions | UNC5B ETF1 ITGA6 ITGA1 TENM2 TUBA1B DDX50 NMT1 FUBP3 DNM2 FLNA RBM15 DSC2 TUBA1C NIBAN2 UPF1 CPT1A NUBP2 CRMP1 KRIT1 TENM3 EGFR ABCE1 PARD3 RPA1 PHLDB2 | 2.98e-04 | 1199 | 209 | 26 | int:RHOA |
| Interaction | DCST2 interactions | 3.19e-04 | 3 | 209 | 2 | int:DCST2 | |
| Interaction | PATJ interactions | 3.31e-04 | 125 | 209 | 7 | int:PATJ | |
| Interaction | RNF113A interactions | AGO2 PHGDH TUBA1B DDX46 DDX50 DLD TAF6 FHL2 HSPA5 TARBP2 FLNA DSG1 TUBA1C UPF1 CPT1A SNIP1 STAU2 RPA1 | 3.34e-04 | 692 | 209 | 18 | int:RNF113A |
| Interaction | NXF1 interactions | ABCA2 WDR81 ITGA6 TUBA4A EMSY WIZ DDX50 SUPT4H1 NMT1 HSPA5 TARBP2 RGPD5 RBM15 ADNP2 CEP192 UPF1 KBTBD2 CPT1A KYAT1 KRIT1 YEATS2 UBE2O EGFR STAU2 WDFY3 SLC25A19 RPA1 CPSF3 | 3.34e-04 | 1345 | 209 | 28 | int:NXF1 |
| Interaction | RNASEH2B interactions | 3.35e-04 | 58 | 209 | 5 | int:RNASEH2B | |
| Interaction | INSL5 interactions | 3.35e-04 | 58 | 209 | 5 | int:INSL5 | |
| GeneFamily | Tubulins | 2.85e-11 | 26 | 152 | 8 | 778 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 5.86e-07 | 9 | 152 | 4 | 1230 | |
| GeneFamily | Desmosomal cadherins | 1.99e-05 | 7 | 152 | 3 | 1188 | |
| GeneFamily | Immunoglobulin like domain containing | 3.77e-05 | 193 | 152 | 9 | 594 | |
| GeneFamily | Fibronectin type III domain containing | 6.30e-05 | 160 | 152 | 8 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.58e-05 | 161 | 152 | 8 | 593 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.49e-04 | 181 | 152 | 8 | 694 | |
| GeneFamily | CD molecules|Type II classical cadherins | 1.57e-04 | 13 | 152 | 3 | 1186 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 4.61e-04 | 163 | 152 | 7 | 590 | |
| GeneFamily | Autophagy related | 2.64e-03 | 33 | 152 | 3 | 1022 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 4.58e-03 | 40 | 152 | 3 | 592 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.58e-03 | 40 | 152 | 3 | 321 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 9.73e-06 | 168 | 212 | 9 | M1124 | |
| Coexpression | SENESE_HDAC1_TARGETS_DN | CADM3 F2R TUBA1A GLI2 NMT2 BCAR1 GSN CRMP1 ZNF503 TNS1 PHLDB2 | 1.23e-05 | 267 | 212 | 11 | M6100 |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN | ITGA6 PHGDH IGLV3-19 FLNA MRAS DSC2 DSG1 MUC16 EGFR LAMP3 KCNK5 PADI2 | 1.44e-05 | 324 | 212 | 12 | M2700 |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.85e-05 | 182 | 212 | 9 | MM993 | |
| Coexpression | SMID_BREAST_CANCER_LUMINAL_B_DN | GALNT3 ITGA6 PHGDH IGLV3-19 UGT8 CCL19 FLNA MRAS DSC2 MUC16 LEPR TIE1 EGFR LAMP3 KCNK5 PADI2 | 2.56e-05 | 587 | 212 | 16 | M17572 |
| Coexpression | LE_EGR2_TARGETS_DN | 2.70e-05 | 107 | 212 | 7 | M15148 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP | 3.45e-05 | 197 | 212 | 9 | M4980 | |
| Coexpression | GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN | 3.73e-05 | 199 | 212 | 9 | M6351 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 3.73e-05 | 199 | 212 | 9 | M5893 | |
| Coexpression | GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP | 3.88e-05 | 200 | 212 | 9 | M6944 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | ITGA6 TUBA4A PHGDH ACAD11 NBEAL2 ELAPOR1 DNM2 SRR BCAR1 GSN ZNF503 UBE2O PPP2R5D ATG3 CKAP2 PADI2 | 4.13e-05 | 611 | 212 | 16 | M1106 |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | ABCA2 ZNF280D UNC5B TENM2 TUBA4A NAV2 CES4A FHL2 PLXNA2 INTS6L FLNA SH3RF1 CPT1A EGFR ABCE1 KRTCAP2 | 4.46e-05 | 615 | 212 | 16 | M8673 |
| Coexpression | LE_EGR2_TARGETS_DN | 4.79e-05 | 117 | 212 | 7 | MM1139 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN | PNO1 ADAM10 MIF NAV2 CDON PRUNE2 IFT81 COX11 PACS1 TENM3 ARHGAP12 WDFY3 PHLDB2 | 6.34e-05 | 438 | 212 | 13 | M227 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN | 7.57e-05 | 54 | 212 | 5 | M1349 | |
| Coexpression | GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP | 7.98e-05 | 171 | 212 | 8 | M7105 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | ITGA6 TUBA4A PHGDH ACAD11 NBEAL2 ELAPOR1 DNM2 SRR BCAR1 GSN ZNF503 UBE2O PPP2R5D ATG3 CKAP2 PADI2 | 8.08e-05 | 647 | 212 | 16 | MM981 |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | ABCA2 ZNF280D UNC5B TENM2 TUBA4A NAV2 CES4A FHL2 PLXNA2 INTS6L FLNA SH3RF1 CPT1A EGFR ABCE1 KRTCAP2 | 1.00e-04 | 659 | 212 | 16 | MM1040 |
| Coexpression | BENPORATH_SUZ12_TARGETS | CADM3 SLC46A2 NEXMIF UNC5B TUBA8 F2R TUBA4A PTGR3 RFTN1 PTCHD1 ELAPOR1 NAV2 PLXNA2 ADCY4 NTRK2 PTPRT CRMP1 ZNF503 CSMD1 PARD3 CDH7 | 1.09e-04 | 1035 | 212 | 21 | M9898 |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | GALNT3 ITGA6 ADAM10 NMT2 AGT DLD NCK2 FLNA DSC2 NTRK2 TUBA1C RNF213 NIBAN2 CPT1A GSN ZNF503 EGFR ARHGAP12 KCNK5 PARD3 OGA CTSD TNS1 PHLDB2 | 1.11e-04 | 1276 | 212 | 24 | M39173 |
| Coexpression | TRAVAGLINI_LUNG_PLATELET_MEGAKARYOCYTE_CELL | TUBA8 F2R TUBA4A F13A1 DCLRE1A FHL2 TREML1 NCK2 FLNA TUBA1C GSN UBE2O PARD3 RPA1 TNS1 | 1.32e-04 | 605 | 212 | 15 | M41691 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | ABCA2 ZNF280D UNC5B TENM2 NAV2 CES4A PLXNA2 INTS6L FLNA SH3RF1 LAMA2 CPT1A EGFR ABCE1 KRTCAP2 | 1.44e-04 | 610 | 212 | 15 | M3854 |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_DN | 1.62e-04 | 142 | 212 | 7 | M6680 | |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | 1.77e-04 | 244 | 212 | 9 | M40312 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_MEGAKARYOCYTE | TMEM185A ITGA6 TUBA8 F2R TUBA4A NBEAL2 DCLRE1A FHL2 TREML1 NCK2 CLIP2 RGS3 UBE2O DENND2C PARD3 TNS1 | 1.80e-04 | 694 | 212 | 16 | M45731 |
| Coexpression | RAF_UP.V1_UP | 1.84e-04 | 193 | 212 | 8 | M2728 | |
| Coexpression | GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN | 1.84e-04 | 193 | 212 | 8 | M3149 | |
| Coexpression | P53_DN.V1_UP | 1.91e-04 | 194 | 212 | 8 | M2698 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN | 1.98e-04 | 195 | 212 | 8 | M10007 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | PNO1 ITGA1 ADAM10 TUBA4A CADM2 MIF NAV2 COBL PLXNA2 CDON PRUNE2 IFT81 COX11 RGS3 PACS1 TENM3 ARHGAP12 WDFY3 PARD3 PHLDB2 | 2.16e-04 | 1009 | 212 | 20 | M157 |
| Coexpression | GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP | 2.19e-04 | 198 | 212 | 8 | M3198 | |
| Coexpression | GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP | 2.27e-04 | 199 | 212 | 8 | M6218 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP | 2.27e-04 | 199 | 212 | 8 | M4058 | |
| Coexpression | GSE360_DC_VS_MAC_L_MAJOR_DN | 2.27e-04 | 199 | 212 | 8 | M5182 | |
| Coexpression | GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP | 2.27e-04 | 199 | 212 | 8 | M5769 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN | 2.35e-04 | 200 | 212 | 8 | M327 | |
| Coexpression | GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP | 2.35e-04 | 200 | 212 | 8 | M7172 | |
| Coexpression | GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN | 2.35e-04 | 200 | 212 | 8 | M9761 | |
| Coexpression | GSE17721_0.5H_VS_12H_CPG_BMDC_UP | 2.35e-04 | 200 | 212 | 8 | M4119 | |
| Coexpression | GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP | 2.35e-04 | 200 | 212 | 8 | M9284 | |
| ToppCell | COVID-19_Mild-PLT_3|COVID-19_Mild / Disease Group and Platelet Clusters | 1.05e-08 | 170 | 214 | 10 | 5ac1252ae3c026a506cfe26e3d119276fe364661 | |
| ToppCell | Control-PLT_3|World / Disease Group and Platelet Clusters | 2.88e-08 | 189 | 214 | 10 | f65c261fe25479e900d5ed1a0d25a9dec302a57b | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.18e-08 | 191 | 214 | 10 | 78ad7c555409ce1391bce406bc0f3ef575329ece | |
| ToppCell | COVID-19_Mild-PLT_3|World / Disease Group and Platelet Clusters | 4.11e-08 | 147 | 214 | 9 | 9d3271aa735ddb6f32ab864d7afcfb0f8754383b | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.26e-08 | 197 | 214 | 10 | a4855c5aebea4f0fed4eb035844572e82e5bac46 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 8.08e-08 | 159 | 214 | 9 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-07 | 181 | 214 | 9 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.68e-07 | 183 | 214 | 9 | 6cbc88c27dc957d182526e84824f70c8e860bf74 | |
| ToppCell | Control|World / Disease Group and Platelet Clusters | 3.36e-07 | 188 | 214 | 9 | f07654b215279abaf1c0882cdf41fbe31580a2ca | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 3.79e-07 | 139 | 214 | 8 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.57e-07 | 195 | 214 | 9 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.57e-07 | 195 | 214 | 9 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-07 | 196 | 214 | 9 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-07 | 196 | 214 | 9 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.98e-07 | 197 | 214 | 9 | d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.98e-07 | 197 | 214 | 9 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.98e-07 | 197 | 214 | 9 | 80b05c8ad9c1edc5dea3236079372475431343fe | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.19e-07 | 198 | 214 | 9 | 7cddd474416651088a4e08edfc0ac420ff10a5fe | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 5.52e-07 | 146 | 214 | 8 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.52e-07 | 146 | 214 | 8 | 45d7cb73776e60d22f335a651845e21e16948fcc | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.65e-07 | 200 | 214 | 9 | 326cae37cacd94b423a6ac8873ea56c5abaf0a0b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.65e-07 | 200 | 214 | 9 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.27e-06 | 163 | 214 | 8 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-06 | 167 | 214 | 8 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 170 | 214 | 8 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 170 | 214 | 8 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 1.90e-06 | 172 | 214 | 8 | 1b24bed3cd8e3fa463c5e7cefdf9e99e639e2f84 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.45e-06 | 178 | 214 | 8 | 44b5ba4e8788d3973749a1717e427647ac4c8579 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 2.78e-06 | 181 | 214 | 8 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | B_cells-ABCs|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.01e-06 | 183 | 214 | 8 | bf9c6fe3ce4e44e4056027257eab8448c39c4fb8 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 3.05e-06 | 129 | 214 | 7 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.40e-06 | 186 | 214 | 8 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 186 | 214 | 8 | 41f1674afc17661eccaa779cdeb663db5e45685d | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.40e-06 | 186 | 214 | 8 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-06 | 186 | 214 | 8 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 186 | 214 | 8 | aa006650cf21a2c51dfe1091681f67fdad939107 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Platelet|World / Lineage, cell class and subclass | 3.40e-06 | 186 | 214 | 8 | 27807334e7241c8a9aeaf6403f0fd0b001fbc0d1 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-06 | 186 | 214 | 8 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-06 | 190 | 214 | 8 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-06 | 190 | 214 | 8 | 5174f91a880f85bb20806023aa68bd4b8ca24ea5 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-06 | 190 | 214 | 8 | 90e494cbfbed33a3a0d29bb7dae83f0c81580bcf | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells|World / Lineage, cell class and subclass | 3.97e-06 | 190 | 214 | 8 | 72b61a12ccea506272ce9cef9051aa2612e6ce57 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-06 | 190 | 214 | 8 | c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.97e-06 | 190 | 214 | 8 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.13e-06 | 191 | 214 | 8 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-06 | 191 | 214 | 8 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.13e-06 | 191 | 214 | 8 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 4.13e-06 | 191 | 214 | 8 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-06 | 192 | 214 | 8 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.29e-06 | 192 | 214 | 8 | d0fb6885f023d55a2b7984c99db9c6463258f788 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 4.46e-06 | 193 | 214 | 8 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | mild_COVID-19_(asymptomatic)-Platelet|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.46e-06 | 193 | 214 | 8 | 9b97a7e9b5c1cc5db353070af0b9c5059714724b | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-06 | 194 | 214 | 8 | 7f24023df47935286f185dd428d48797daf26f49 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 4.63e-06 | 194 | 214 | 8 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 4.81e-06 | 195 | 214 | 8 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 4.81e-06 | 195 | 214 | 8 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-06 | 195 | 214 | 8 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-06 | 195 | 214 | 8 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.00e-06 | 196 | 214 | 8 | 66ba31b74953726e9c314f6d8fe3f75d3762e23a | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|(2)_5-FU / Stress and Cell class | 5.00e-06 | 196 | 214 | 8 | cc0a172de71d9a1a882c9e78652dae70e007d012 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-06 | 196 | 214 | 8 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-06 | 196 | 214 | 8 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.01e-06 | 139 | 214 | 7 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | COVID-19-kidney-Technical/muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.01e-06 | 139 | 214 | 7 | 13247bcb21c57c808657e0f543d6f134eeea7cc1 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.19e-06 | 197 | 214 | 8 | 61c1c29a62d4c033999b7f0183c1e9cdd6a62925 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.19e-06 | 197 | 214 | 8 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.19e-06 | 197 | 214 | 8 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 5.19e-06 | 197 | 214 | 8 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.19e-06 | 197 | 214 | 8 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-06 | 197 | 214 | 8 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.19e-06 | 197 | 214 | 8 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-06 | 197 | 214 | 8 | ee8f7def9d5af7b1e636830a4ea1da158d02f25a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.25e-06 | 140 | 214 | 7 | 72c272f44e5600b3037c1dbf9d3a4669a35588d8 | |
| ToppCell | Control-PLT_3|Control / Disease Group and Platelet Clusters | 5.25e-06 | 140 | 214 | 7 | 82ea671f61d55f6896d903c5876b042e2f3385d6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.38e-06 | 198 | 214 | 8 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.38e-06 | 198 | 214 | 8 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.38e-06 | 198 | 214 | 8 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.38e-06 | 198 | 214 | 8 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.38e-06 | 198 | 214 | 8 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.38e-06 | 198 | 214 | 8 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.38e-06 | 198 | 214 | 8 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.38e-06 | 198 | 214 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 5.59e-06 | 199 | 214 | 8 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.59e-06 | 199 | 214 | 8 | 236b1417ed0875e98c6ec1ec714003bfce438d65 | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 5.59e-06 | 199 | 214 | 8 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.80e-06 | 200 | 214 | 8 | 86ec951234015ced7126b016199e5869a0f22478 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 5.80e-06 | 200 | 214 | 8 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | MS-IIF-Others-Platelet|IIF / Disease, condition lineage and cell class | 5.80e-06 | 200 | 214 | 8 | 2254319216f1c2e0a0f015ea530c1e6a55a92d5d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.80e-06 | 200 | 214 | 8 | 061ba851f941c616ddb462512e826c412881c3ce | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 7.56e-06 | 148 | 214 | 7 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.56e-06 | 148 | 214 | 7 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.26e-06 | 150 | 214 | 7 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | VE-CD8-memory_CD4|VE / Condition, Cell_class and T cell subcluster | 9.01e-06 | 152 | 214 | 7 | 9401b7770c1bdc87eba25e82922f5dd1c4fa37ee | |
| ToppCell | facs-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 165 | 214 | 7 | 720649f330382ea2a68c64a5344160a048afb8f1 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 165 | 214 | 7 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 165 | 214 | 7 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 167 | 214 | 7 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-05 | 169 | 214 | 7 | 0d8b681404e18f3061d84425fb5f7d84e8e2b8d7 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Megakaryocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.86e-05 | 170 | 214 | 7 | eace4dd09cdbde0fa40a6aa0f3dba1114d0ce475 | |
| Drug | Epothilone D | 4.91e-10 | 12 | 209 | 6 | DB01873 | |
| Drug | Epothilone B | 4.91e-10 | 12 | 209 | 6 | DB03010 | |
| Drug | Aids106696 | 6.53e-09 | 29 | 209 | 7 | CID006475933 | |
| Drug | indibulin | 1.10e-07 | 26 | 209 | 6 | CID000002929 | |
| Drug | tryprostatin A | 2.66e-07 | 48 | 209 | 7 | CID009929833 | |
| Drug | citostal | 2.75e-07 | 30 | 209 | 6 | CID000018991 | |
| Drug | NSC609395 | 3.39e-07 | 31 | 209 | 6 | CID005488798 | |
| Drug | DTAF | 1.02e-06 | 37 | 209 | 6 | CID000123934 | |
| Drug | albendazole | 1.02e-06 | 37 | 209 | 6 | CID000002082 | |
| Drug | baccatin III | 1.02e-06 | 37 | 209 | 6 | CID000065366 | |
| Drug | B-Ms | 1.10e-06 | 114 | 209 | 9 | CID000445091 | |
| Drug | bromocolchicine | 1.12e-06 | 21 | 209 | 5 | CID000161518 | |
| Drug | colchifoline | 1.12e-06 | 21 | 209 | 5 | CID000100132 | |
| Drug | Ustiloxin A | 1.12e-06 | 21 | 209 | 5 | CID000164454 | |
| Drug | SRI-3072 | 1.12e-06 | 21 | 209 | 5 | CID000493469 | |
| Drug | laulimalide | 1.20e-06 | 38 | 209 | 6 | CID006918457 | |
| Drug | Dolastatin 10 | 1.41e-06 | 39 | 209 | 6 | CID000100208 | |
| Drug | 3,4,5-trimethoxyacetophenone | 1.44e-06 | 22 | 209 | 5 | CID000014345 | |
| Drug | AC1L1GIQ | 1.44e-06 | 22 | 209 | 5 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 1.44e-06 | 22 | 209 | 5 | CID000098538 | |
| Drug | SureCN13401588 | 1.44e-06 | 22 | 209 | 5 | CID009897422 | |
| Drug | N-methyldemecolcine | 1.44e-06 | 22 | 209 | 5 | CID000023759 | |
| Drug | NSC-339672 | 1.44e-06 | 22 | 209 | 5 | CID000433930 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 1.83e-06 | 23 | 209 | 5 | CID000006858 | |
| Drug | AC1L2P05 | 1.83e-06 | 23 | 209 | 5 | CID000125688 | |
| Drug | 2,3,4-tabp | 1.83e-06 | 23 | 209 | 5 | CID000125548 | |
| Drug | NSC-373301 | 1.83e-06 | 23 | 209 | 5 | CID000341375 | |
| Drug | NSC355636 | 1.83e-06 | 23 | 209 | 5 | CID000100176 | |
| Drug | IKP104 | 1.83e-06 | 23 | 209 | 5 | CID000130739 | |
| Drug | fluorescein-colchicine | 1.83e-06 | 23 | 209 | 5 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 1.83e-06 | 23 | 209 | 5 | CID000084076 | |
| Drug | 2,3,4-TCB | 1.83e-06 | 23 | 209 | 5 | CID000129239 | |
| Drug | N-acetylcolchinol | 1.83e-06 | 23 | 209 | 5 | CID000097865 | |
| Drug | lonafarnib | 2.22e-06 | 124 | 209 | 9 | CID000148195 | |
| Drug | parbendazole | 2.29e-06 | 24 | 209 | 5 | CID000026596 | |
| Drug | tropolone methyl ether | 2.29e-06 | 24 | 209 | 5 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 2.29e-06 | 24 | 209 | 5 | CID000330401 | |
| Drug | NABV | 2.29e-06 | 24 | 209 | 5 | CID000175959 | |
| Drug | AC1L4TG7 | 2.29e-06 | 24 | 209 | 5 | CID000163705 | |
| Drug | moscatilin | 2.29e-06 | 24 | 209 | 5 | CID000176096 | |
| Drug | NSC-36768 | 2.29e-06 | 24 | 209 | 5 | CID000165441 | |
| Drug | deacetamidocolchicine | 2.29e-06 | 24 | 209 | 5 | CID000014995 | |
| Drug | colchicide | 2.29e-06 | 24 | 209 | 5 | CID000120712 | |
| Drug | Imipenem [74431-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.44e-06 | 199 | 209 | 11 | 5997_UP | |
| Drug | mpMap | 2.84e-06 | 25 | 209 | 5 | CID000100806 | |
| Drug | AC1Q6P06 | 2.84e-06 | 25 | 209 | 5 | CID000160263 | |
| Drug | allocolchicine | 2.84e-06 | 25 | 209 | 5 | CID000196989 | |
| Drug | 1069C85 | 2.84e-06 | 25 | 209 | 5 | CID006918099 | |
| Drug | 55623-37-5 | 2.84e-06 | 25 | 209 | 5 | CID006438440 | |
| Drug | MDL 27048 | 2.84e-06 | 25 | 209 | 5 | CID006439188 | |
| Drug | NBD-colcemid | 2.84e-06 | 25 | 209 | 5 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 2.84e-06 | 25 | 209 | 5 | CID000043264 | |
| Drug | CA1P | 2.84e-06 | 25 | 209 | 5 | CID006918545 | |
| Drug | peloruside A | 2.84e-06 | 25 | 209 | 5 | CID006918506 | |
| Drug | NSC142227 | 2.84e-06 | 25 | 209 | 5 | CID000073427 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 3.03e-06 | 4 | 209 | 3 | DB07574 | |
| Drug | NSC527981 | 3.49e-06 | 26 | 209 | 5 | CID000352796 | |
| Drug | NSC332029 | 3.49e-06 | 26 | 209 | 5 | CID000100073 | |
| Drug | pironetin | 3.49e-06 | 26 | 209 | 5 | CID006438891 | |
| Drug | isaxonine | 3.49e-06 | 26 | 209 | 5 | CID000071169 | |
| Drug | trifluralin | 3.50e-06 | 131 | 209 | 9 | CID000005569 | |
| Drug | AC1L1J4H | 4.26e-06 | 27 | 209 | 5 | CID000004862 | |
| Drug | dinitroanilines | 4.26e-06 | 27 | 209 | 5 | CID000136400 | |
| Drug | NSC292222 | 4.26e-06 | 27 | 209 | 5 | CID000099957 | |
| Drug | NSC D-669356 | 4.26e-06 | 27 | 209 | 5 | CID000178028 | |
| Drug | GTP - Na | ETF1 TUBA3E TUBA8 F2R TUBA4A TUBA1B PTK2B AP2A1 TUBA1A TAF6 DNM1 TAF10 TARBP2 DNM2 ADSS1 ADCY4 MRAS TUBA1C PRR5 BCAR1 KRIT1 EGFR ARHGAP12 RPA1 | 4.57e-06 | 923 | 209 | 24 | CID000000762 |
| Drug | Taxane | 4.97e-06 | 103 | 209 | 8 | CID000108169 | |
| Drug | NSC 370147 | 5.14e-06 | 28 | 209 | 5 | CID000182762 | |
| Drug | NSC72302 | 5.14e-06 | 28 | 209 | 5 | CID000118078 | |
| Drug | NSC654663 | 5.60e-06 | 49 | 209 | 6 | CID000375252 | |
| Drug | bp U | 6.17e-06 | 29 | 209 | 5 | CID000368697 | |
| Drug | oxibendazole | 6.17e-06 | 29 | 209 | 5 | CID000004622 | |
| Drug | ddGDP | 6.17e-06 | 29 | 209 | 5 | CID000134739 | |
| Drug | TK-B | 7.11e-06 | 51 | 209 | 6 | CID000009074 | |
| Drug | AC1NBBHE | 7.34e-06 | 30 | 209 | 5 | CID004490620 | |
| Drug | eleutherobin | 7.34e-06 | 30 | 209 | 5 | CID006918335 | |
| Drug | azatoxin | 7.34e-06 | 30 | 209 | 5 | CID000125383 | |
| Drug | NSC617668 | 7.34e-06 | 30 | 209 | 5 | CID000357989 | |
| Drug | thiocolchicine | 7.34e-06 | 30 | 209 | 5 | CID000017648 | |
| Drug | vinflunine | 7.97e-06 | 52 | 209 | 6 | CID000157688 | |
| Drug | amiprophosmethyl | 8.69e-06 | 31 | 209 | 5 | CID000100524 | |
| Drug | AC7700 | 8.69e-06 | 31 | 209 | 5 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 8.69e-06 | 31 | 209 | 5 | CID000032851 | |
| Drug | tropone | 8.69e-06 | 31 | 209 | 5 | CID000010881 | |
| Drug | AC1L3V8I | 8.69e-06 | 31 | 209 | 5 | CID000122777 | |
| Drug | NSC332598 | 8.69e-06 | 31 | 209 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 8.69e-06 | 31 | 209 | 5 | CID000023678 | |
| Drug | S)-monastrol | 9.96e-06 | 54 | 209 | 6 | CID000794323 | |
| Drug | AC1L1G95 | 1.02e-05 | 32 | 209 | 5 | CID000003583 | |
| Drug | NSC153858 | 1.02e-05 | 32 | 209 | 5 | CID000547450 | |
| Drug | E2-3,4-Q | 1.02e-05 | 32 | 209 | 5 | CID000067402 | |
| Drug | 2-demethylcolchicine | 1.02e-05 | 32 | 209 | 5 | CID000023757 | |
| Drug | mebendazole | 1.20e-05 | 33 | 209 | 5 | CID000004030 | |
| Drug | CA4P | 1.20e-05 | 33 | 209 | 5 | CID000370232 | |
| Drug | taltobulin | 1.20e-05 | 33 | 209 | 5 | CID006918637 | |
| Drug | AC1L8WWP | 1.23e-05 | 56 | 209 | 6 | CID000388944 | |
| Drug | 2,5-hexanedione | 1.23e-05 | 56 | 209 | 6 | CID000008035 | |
| Drug | (+,-)-Synephrine [94-07-5]; Up 200; 24uM; MCF7; HT_HG-U133A | 1.24e-05 | 193 | 209 | 10 | 3578_UP | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 1.36e-05 | 195 | 209 | 10 | 5618_DN | |
| Drug | triethyllead | 1.39e-05 | 34 | 209 | 5 | CID006328106 | |
| Disease | microlissencephaly (implicated_via_orthology) | 4.55e-18 | 8 | 204 | 8 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 4.55e-18 | 8 | 204 | 8 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 4.55e-18 | 8 | 204 | 8 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 9.02e-12 | 27 | 204 | 8 | DOID:0050453 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | PPP1R12B PER1 ADAM10 EMSY PHGDH MIF ELAPOR1 MTMR3 KDR FHL2 TREML1 FLNA ATG10 LAMA2 BCAR1 CPT1A LEPR GSN EPG5 EGFR TNS1 CPSF3 ENPEP EP300 | 4.72e-07 | 1074 | 204 | 24 | C0006142 |
| Disease | Mammary Carcinoma, Human | PPP1R12B ADAM10 EMSY PHGDH MIF KDR FHL2 FLNA ATG10 CPT1A LEPR EGFR EP300 | 8.14e-05 | 525 | 204 | 13 | C4704874 |
| Disease | Mammary Neoplasms, Human | PPP1R12B ADAM10 EMSY PHGDH MIF KDR FHL2 FLNA ATG10 CPT1A LEPR EGFR EP300 | 8.14e-05 | 525 | 204 | 13 | C1257931 |
| Disease | Mammary Neoplasms | PPP1R12B ADAM10 EMSY PHGDH MIF KDR FHL2 FLNA ATG10 CPT1A LEPR EGFR EP300 | 8.46e-05 | 527 | 204 | 13 | C1458155 |
| Disease | white matter microstructure measurement | NBEAL1 TENM2 ACAD11 NAV2 NMT1 STPG2 SEMA3D TIE1 EGFR WDFY3 CPNE7 | 9.33e-05 | 390 | 204 | 11 | EFO_0005674 |
| Disease | coronary aneurysm | 9.82e-05 | 35 | 204 | 4 | EFO_1000881 | |
| Disease | Breast Carcinoma | PPP1R12B ADAM10 EMSY PHGDH MIF KDR FHL2 FLNA ATG10 CPT1A LEPR EGFR EP300 | 1.04e-04 | 538 | 204 | 13 | C0678222 |
| Disease | airway imaging measurement | 1.36e-04 | 38 | 204 | 4 | EFO_0007627 | |
| Disease | complement factor H-related protein 3 measurement | 1.82e-04 | 169 | 204 | 7 | EFO_0600056 | |
| Disease | Nodular glomerulosclerosis | 1.84e-04 | 41 | 204 | 4 | C0017667 | |
| Disease | blood nickel measurement | 1.93e-04 | 120 | 204 | 6 | EFO_0007583 | |
| Disease | Diabetic Nephropathy | 2.43e-04 | 44 | 204 | 4 | C0011881 | |
| Disease | Hyperphagia | 2.83e-04 | 4 | 204 | 2 | C0020505 | |
| Disease | Osteochondrodysplasias | 2.91e-04 | 19 | 204 | 3 | C0029422 | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 4.69e-04 | 5 | 204 | 2 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 4.69e-04 | 5 | 204 | 2 | DOID:11252 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 4.69e-04 | 5 | 204 | 2 | DOID:0110197 (implicated_via_orthology) | |
| Disease | muscular disease (implicated_via_orthology) | 4.69e-04 | 5 | 204 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | mean fractional anisotropy measurement | 5.26e-04 | 95 | 204 | 5 | EFO_0008399 | |
| Disease | Alcoholic Intoxication, Chronic | 5.85e-04 | 268 | 204 | 8 | C0001973 | |
| Disease | Albuminuria | 5.92e-04 | 24 | 204 | 3 | C0001925 | |
| Disease | neuroticism measurement, cognitive function measurement | HIVEP1 AGO2 NBEAL1 PPP1R12B CADM2 PTPRO NAV2 TENM3 CSMD1 OGA CDH7 CDH12 | 6.18e-04 | 566 | 204 | 12 | EFO_0007660, EFO_0008354 |
| Disease | diffuse scleroderma (is_marker_for) | 7.01e-04 | 6 | 204 | 2 | DOID:1580 (is_marker_for) | |
| Disease | peak expiratory flow | ITGA1 PHGDH SFXN2 KDR SH3RF1 PACS1 EYS BBS7 STAU2 PHLDB2 KRTCAP2 | 7.44e-04 | 498 | 204 | 11 | EFO_0009718 |
| Disease | myocardial infarction | 7.83e-04 | 350 | 204 | 9 | EFO_0000612 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 8.43e-04 | 27 | 204 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | lumbar disc degeneration | 9.39e-04 | 28 | 204 | 3 | EFO_0004994 | |
| Disease | breast carcinoma (is_marker_for) | 1.14e-03 | 66 | 204 | 4 | DOID:3459 (is_marker_for) | |
| Disease | body weight | HIVEP1 NBEAL1 NEXMIF C3orf38 GON4L DCST2 CADM2 MTMR3 UGT8 UNC79 MPZ MRAS SH3RF1 NTRK2 CEP192 PTPRT EYS RPA1 CDH7 | 1.26e-03 | 1261 | 204 | 19 | EFO_0004338 |
| Disease | microcephaly (is_implicated_in) | 1.30e-03 | 8 | 204 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | hypertension (is_implicated_in) | 1.56e-03 | 121 | 204 | 5 | DOID:10763 (is_implicated_in) | |
| Disease | mitral valve prolapse (is_implicated_in) | 1.66e-03 | 9 | 204 | 2 | DOID:988 (is_implicated_in) | |
| Disease | response to lamotrigine | 1.66e-03 | 9 | 204 | 2 | EFO_0007661 | |
| Disease | isovalerate measurement | 1.66e-03 | 9 | 204 | 2 | EFO_0021051 | |
| Disease | synaptotagmin-11 measurement | 1.66e-03 | 9 | 204 | 2 | EFO_0802108 | |
| Disease | post-traumatic stress disorder (biomarker_via_orthology) | 1.66e-03 | 9 | 204 | 2 | DOID:2055 (biomarker_via_orthology) | |
| Disease | pentachlorophenol measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022071 | |
| Disease | parathion measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022070 | |
| Disease | potassium chromate measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022067 | |
| Disease | methoxychlor measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022055 | |
| Disease | aldrin measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022054 | |
| Disease | dicofol measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022060 | |
| Disease | disulfoton measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022062 | |
| Disease | dieldrin measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022061 | |
| Disease | endrin measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022064 | |
| Disease | endosulfan measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022063 | |
| Disease | heptachlor measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022066 | |
| Disease | ethion measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022056 | |
| Disease | diazinon measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0022058 | |
| Disease | environmental exposure measurement | 1.66e-03 | 73 | 204 | 4 | EFO_0008360 | |
| Disease | pursuit maintenance gain measurement | 1.68e-03 | 123 | 204 | 5 | EFO_0008433 | |
| Disease | loneliness measurement | 1.74e-03 | 124 | 204 | 5 | EFO_0007865 | |
| Disease | DDT metabolite measurement | 1.75e-03 | 74 | 204 | 4 | EFO_0007886 | |
| Disease | emphysema | 1.81e-03 | 35 | 204 | 3 | EFO_0000464 | |
| Disease | hematocrit | HIVEP1 NBEAL1 ITGA1 PHGDH ACAD11 MTMR3 UGT8 IFT81 RGS3 GSN SEMA3D TIE1 KCNK5 SLC25A19 PADI2 PSD4 | 1.87e-03 | 1011 | 204 | 16 | EFO_0004348 |
| Disease | hypertension (implicated_via_orthology) | 2.00e-03 | 128 | 204 | 5 | DOID:10763 (implicated_via_orthology) | |
| Disease | postburn hypertrophic scarring severity measurement | 2.06e-03 | 10 | 204 | 2 | EFO_0007747 | |
| Disease | hydroxyproline measurement | 2.06e-03 | 10 | 204 | 2 | EFO_0010498 | |
| Disease | reaction time measurement | TENM2 CADM2 PTPRO CNTN5 NAV2 SFXN2 PLXNA2 DNM2 TUBA1C CEP192 CSMD1 CDH7 | 2.21e-03 | 658 | 204 | 12 | EFO_0008393 |
| Disease | waist-hip ratio | ZNF280D DCST2 F2R CADM2 PTGR3 FCGR1BP CNTN5 CDON PRUNE2 MRAS NTRK2 CEP192 KBTBD2 TRIM33 YEATS2 SEMA3D KCNK5 PHLDB2 | 2.24e-03 | 1226 | 204 | 18 | EFO_0004343 |
| Disease | Internal Carotid Artery Diseases | 2.51e-03 | 11 | 204 | 2 | C0750986 | |
| Disease | Arterial Diseases, Common Carotid | 2.51e-03 | 11 | 204 | 2 | C0750987 | |
| Disease | Carotid Atherosclerosis | 2.51e-03 | 11 | 204 | 2 | C0577631 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 2.51e-03 | 11 | 204 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Diabetic Cardiomyopathies | 2.51e-03 | 11 | 204 | 2 | C0853897 | |
| Disease | External Carotid Artery Diseases | 2.51e-03 | 11 | 204 | 2 | C0600178 | |
| Disease | Carotid Artery Diseases | 2.51e-03 | 11 | 204 | 2 | C0007273 | |
| Disease | Cognitive impairment | 2.51e-03 | 11 | 204 | 2 | HP_0100543 | |
| Disease | beverage consumption measurement | 2.66e-03 | 83 | 204 | 4 | EFO_0010088 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 3.00e-03 | 12 | 204 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | collagen disease (implicated_via_orthology) | 3.00e-03 | 12 | 204 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | high grade glioma (is_marker_for) | 3.07e-03 | 42 | 204 | 3 | DOID:3070 (is_marker_for) | |
| Disease | Obesity | 3.12e-03 | 205 | 204 | 6 | C0028754 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.19e-03 | 206 | 204 | 6 | C0152013 | |
| Disease | neuroimaging measurement | VWA5B2 NBEAL1 TUBA1B ACAD11 NAV2 MAP3K11 PLXNA2 LAMA2 STPG2 CRMP1 SEMA3D EGFR ARHGAP12 PARD3 TNS1 KRTCAP2 | 3.24e-03 | 1069 | 204 | 16 | EFO_0004346 |
| Disease | Proteinuria | 3.28e-03 | 43 | 204 | 3 | C0033687 | |
| Disease | suicide behaviour measurement | 3.28e-03 | 43 | 204 | 3 | EFO_0006882 | |
| Disease | response to radiation | 3.29e-03 | 88 | 204 | 4 | GO_0009314 | |
| Disease | Kidney Diseases | 3.29e-03 | 88 | 204 | 4 | C0022658 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 3.53e-03 | 13 | 204 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | eye color | 3.57e-03 | 90 | 204 | 4 | EFO_0003949 | |
| Disease | obesity (is_implicated_in) | 3.71e-03 | 91 | 204 | 4 | DOID:9970 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 4.01e-03 | 93 | 204 | 4 | C1535926 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 4.02e-03 | 216 | 204 | 6 | EFO_0007925, EFO_0007927 | |
| Disease | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | 4.10e-03 | 14 | 204 | 2 | EFO_0004307, EFO_0008464 | |
| Disease | bipolar disorder, response to lithium ion | 4.10e-03 | 14 | 204 | 2 | GO_0010226, MONDO_0004985 | |
| Disease | fat body mass | 4.11e-03 | 217 | 204 | 6 | EFO_0005409 | |
| Disease | social interaction measurement | 4.17e-03 | 94 | 204 | 4 | EFO_0009592 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSSVIVQPFSKPGYI | 116 | Q6N043 | |
| GPVTISQPSVVKNYI | 946 | Q68DN1 | |
| YLPRTQAAGPVSQGK | 1886 | Q09472 | |
| AYKLQPTPGIQKVGI | 1656 | Q9HCE0 | |
| GTLQAYVTPRIQPKT | 466 | Q8IWZ6 | |
| NSSPVLSKVPGYGLQ | 216 | Q9NXE8 | |
| SFPPNGNKIGTLTVY | 2626 | Q96PZ7 | |
| VKQTQAIPYTGPFNL | 511 | Q9UKF6 | |
| LVPTPSKAQQGLYQV | 116 | P56945 | |
| GIITVQNYGSHVPPK | 361 | O14672 | |
| DSGNVFLPPVIKYTI | 971 | Q86UK0 | |
| YGGAPQALTLKLPVT | 846 | O95782 | |
| AVTKGIVSLPPSYQI | 471 | P10632 | |
| FKNGIITGVYPASPS | 46 | P50416 | |
| PTQLSKIKYSGGPQI | 66 | Q14738 | |
| PVVAGVIGAQKPQYD | 991 | Q8NFM4 | |
| KPGVVQYLGETQFAP | 91 | Q9UDT6 | |
| VGPVVGLNLPLSYAK | 196 | Q9H0Y0 | |
| VLGIPQKPIITGYKS | 126 | Q8N126 | |
| YGNVISIFEPVNLPK | 76 | Q9Y485 | |
| KYSIIGQVPPSPTLF | 281 | Q02487 | |
| YLPTGKQFLVTKNVP | 66 | Q9NT62 | |
| TPGVKIIRPLSVFGY | 576 | Q709F0 | |
| QLVVVILPGKTPVYA | 516 | Q9UKV8 | |
| QLIPTGKQVNGIPTY | 601 | Q6IQ32 | |
| GKQVNGIPTYTLAPV | 606 | Q6IQ32 | |
| KQPFVQGLALYTPVV | 211 | P01019 | |
| PKKPVLGSYRGQIVQ | 171 | Q8WWK9 | |
| VPPLTPFEVKVGVYN | 841 | O94779 | |
| VPVGLASKPFQILYG | 2476 | Q6ZS30 | |
| YQPLGALVVTTPQAV | 151 | Q9Y5Y2 | |
| NLYPTVGLQTPGEVV | 311 | Q96S59 | |
| VPSDNLPTYKLVVVG | 6 | O14807 | |
| RNPIKIGYGKATPTT | 441 | Q96T37 | |
| PGNIYSTLKRPQVET | 16 | Q14699 | |
| YPVTIPLHVSKNGQT | 296 | Q14699 | |
| YVASVLGLTPSPRQK | 11 | Q99666 | |
| YVASVLGLTPSPRQK | 11 | O14715 | |
| GTYVTLAPKVLVFPV | 541 | P49796 | |
| LIYVRPNSKTGVPVG | 271 | Q5JSJ4 | |
| VYDPQKATVVPVLAG | 106 | Q8WV74 | |
| VPPRAVINSAGYKIL | 111 | Q96TA1 | |
| SPGVYKSRAPQFTIL | 191 | A8MYP8 | |
| DTVPRAAQPGYLVTK | 576 | Q9Y5F8 | |
| ISQYTVKGLQLPTPV | 181 | Q92637 | |
| QKPGQSPVLVIYQDS | 56 | P01715 | |
| IPPALNSVIYGVRTK | 281 | Q8NGJ3 | |
| PVVNVGTVIYKHLSP | 8646 | Q8WXI7 | |
| RPVFKNTSVGPLYSG | 13516 | Q8WXI7 | |
| VNGGPLKPEITVSYI | 31 | Q0GE19 | |
| KEQNSPIYISRVIPG | 111 | Q9HAP6 | |
| DTYPVDQGPKQTGIV | 1286 | Q5T1H1 | |
| TGLVPPVDKNVVGYR | 226 | A8MVJ9 | |
| GTPNKPSVAVRVLSY | 236 | P06870 | |
| IFQAVYTAGVVLPKP | 276 | P30419 | |
| AVYTAGVVLPKPIAT | 281 | O60551 | |
| LVPKNYVVVLSDGPA | 246 | O43639 | |
| TNKGISPVPINLRVY | 111 | Q05193 | |
| LSVTQKPIPGYIVRN | 31 | Q99731 | |
| PEVTGYKAGVSSQPV | 746 | Q6UXG2 | |
| RVYNIEFNPPKTVGI | 136 | Q9UIJ7 | |
| YQAAAPVLTPAKVTG | 116 | Q8N6L1 | |
| LTAKQVLSPGFYEIP | 551 | Q86SJ6 | |
| KLPVIPGSNAVFYTT | 56 | Q5CZC0 | |
| YVTKIRVSDGAPAQP | 321 | O15534 | |
| PPASGGAKLNYTVLI | 1171 | O75051 | |
| YNILTIKATDSGQPP | 1311 | Q9NYQ8 | |
| ITTIGYGNVAPKTPA | 96 | O95279 | |
| GSIAYVKPISNSPPV | 256 | Q8NHC6 | |
| PLVLLTQGKVSSVPY | 331 | Q5XG92 | |
| VVVGLYGKPSLSAQP | 216 | Q8N743 | |
| PGGVQEITYTVPADK | 351 | Q96I24 | |
| GLPPNDKSVVVQGLY | 236 | Q8IY47 | |
| GVKYIIVTQVGPGPQ | 366 | P53602 | |
| TYIPVPIVSELQSGK | 116 | P00488 | |
| QDVIYFPPKILTSVG | 331 | P48357 | |
| LAPQPSSVKTGIYQV | 216 | Q9UQV4 | |
| YVVETTKPISPANQG | 71 | O00522 | |
| LAVVQQKPAFGQYPG | 1171 | P10070 | |
| IAYVIVKAANSPRPG | 136 | P24043 | |
| QLAQATGKPPQYIAV | 26 | P14174 | |
| SNSGKPLTIYVQPEQ | 301 | Q07075 | |
| INTKPTQVLKGISPY | 456 | P23229 | |
| GNPPSKVYGNIRAVA | 231 | Q9NRX1 | |
| PVTVNGKTYPLGRIL | 416 | Q9Y2J8 | |
| SPLVGQPKNRTGDVY | 66 | P56199 | |
| TNKGISPVPINLRVY | 111 | P50570 | |
| RGFQKGQVTVTQPYP | 91 | Q8TE96 | |
| GIDQPPYGIFVINQK | 91 | Q02413 | |
| YLGQPVKHAVITVPT | 136 | P48741 | |
| PRPVKVAAVGGQSYL | 621 | Q6VY07 | |
| YQSIAIVFGPTLLKP | 801 | Q8IWW6 | |
| TIYIPPSIKGGNVTT | 1541 | Q96RW7 | |
| SSKPIIENLVPGAQY | 491 | Q16827 | |
| LKPAQSRGAPVSVYQ | 611 | O14522 | |
| PSVYTGVFVVSLPLN | 106 | P25116 | |
| EAVGVKIGNPVPYNE | 106 | P27694 | |
| AKPDQIGIITPYEGQ | 796 | Q92900 | |
| EYINQSVPKRPAGSV | 1091 | P00533 | |
| GGEVPVLNVSYKPQK | 401 | P61221 | |
| FRQGLVIGSKPVIYP | 86 | Q8WYA0 | |
| GSYKVGPQAPVTDVL | 156 | H3BNL1 | |
| NPRAPVIIYKQTKGG | 361 | Q8NHQ1 | |
| NTYTVKYTPVQQGPV | 931 | P21333 | |
| KYTPVQQGPVGVNVT | 936 | P21333 | |
| TDKPVIGISTYNIVP | 191 | Q9Y6N1 | |
| LNPVISGYIKSVGQP | 501 | Q14435 | |
| LIAKGPVSKYSQAVP | 46 | P07339 | |
| IFKYLATQGIVIPPA | 71 | Q5JPI3 | |
| QLYGPTNVAPIISKV | 481 | Q9UBL6 | |
| PNVVYVGGILTKPAS | 256 | Q16880 | |
| VGIPKYPVVSEAANN | 691 | Q4KMG0 | |
| YAGKAPVLAAPPVTV | 896 | O75128 | |
| PQFPPTTGAVLYTVK | 1981 | Q3T8J9 | |
| GVTYLFPIQVKTFGP | 156 | Q9BQ39 | |
| AYLTVLGVPEKPQIS | 116 | Q8N3J6 | |
| PKSKGNPAAYGITVT | 1756 | Q9BZC7 | |
| KIPNIYAIGDVVAGP | 346 | P09622 | |
| VVSLQKKPSGISYIP | 496 | Q68D51 | |
| KNPFLGIAYIAVGSI | 321 | Q9NV96 | |
| KKPITTGGVTYREQP | 166 | Q14192 | |
| VQPFGPQYEVVLKGE | 1731 | Q8TEP8 | |
| ILQGQPYFSVDPKTG | 201 | Q13634 | |
| QPYFSIDPKTGVIRT | 206 | P55289 | |
| YPKQTQVSVLPEGGE | 371 | P06396 | |
| QPAAKIIPTKIVYGQ | 646 | Q7Z589 | |
| VIPQTKGNISIYGIP | 976 | Q6PJP8 | |
| KYIQPFLRQTIGTPV | 256 | Q5T1A1 | |
| LQGQPYFSVEPKTGV | 196 | Q9ULB5 | |
| LPPEGYVVVVKNVGL | 901 | Q14289 | |
| GYEKPTPIQTQAIPA | 391 | Q7L014 | |
| IVQPIISKLYGSAGP | 626 | P11021 | |
| PVIKISYSTPQGKGE | 251 | Q6NUJ5 | |
| SYSTPQGKGEVVKIP | 256 | Q6NUJ5 | |
| YEINGLTPTTVPPKN | 3126 | Q6ZTR5 | |
| DVGPQAPVGSVYQKT | 151 | Q9UJU6 | |
| IPGGIDVNTYLQKPS | 66 | Q14194 | |
| AYGVAVNKLTLPIPS | 331 | Q16584 | |
| PIPVDAKVGYGTSQS | 811 | Q13615 | |
| TIGGSAPIYVKNILP | 481 | Q8TEW0 | |
| AGSGVKPKPQVYSTL | 156 | Q9Y6K5 | |
| VFPPALNSVIYGVKT | 281 | Q8NH55 | |
| APSGPGSVQKYIVVS | 596 | P49848 | |
| GSVQKYIVVSLPPTG | 601 | P49848 | |
| LVVNSPVYVGGIPQE | 1831 | O75445 | |
| PVAIQTYPILGEKIT | 6 | Q8TED0 | |
| VYQVKISPTPQLGAA | 16 | Q8NHV9 | |
| LVIESKPAPGYTPNV | 476 | Q9UPN9 | |
| FNDGSVKTPGPIVIY | 596 | Q8IWZ5 | |
| VKTPGPIVIYQTLVY | 601 | Q8IWZ5 | |
| TNTFRGVVIKYSEPP | 236 | Q8TAD8 | |
| IPPQNIGDVYGVVKA | 286 | Q8N142 | |
| GVVPPGTQVEQLLYA | 56 | Q96NB2 | |
| VYVLPSAANGDVKPV | 96 | Q12962 | |
| TVLPPIGYQADIKGS | 2166 | Q8WUY3 | |
| LPSRPVKQGEVVTAY | 296 | Q8N3T6 | |
| ARVVITQSPGKYVLP | 326 | Q8NFB2 | |
| APVLVIYGKNNRPSG | 61 | P01714 | |
| PNVSQSPYLRTVGEK | 226 | O60502 | |
| QAIFYPVQGKEPSVR | 131 | P85299 | |
| AVTKIQVPRPGFNYT | 121 | Q96NR3 | |
| ANVTTNIPVIPGGYL | 801 | Q5QGS0 | |
| SVGLKPIIPQGSYFL | 326 | Q16773 | |
| GLSVGLAPKPVQVLY | 2536 | Q6ZNJ1 | |
| TYPSQIPLKSQVLQG | 51 | Q8IVL1 | |
| QDPTVPTYKQGILAR | 771 | Q8NDX1 | |
| GYVLGAPLVKVPENT | 281 | Q86UG4 | |
| GTPLVGVNVSFVKYP | 941 | Q9NT68 | |
| PPQTSLVKFVGNIYT | 1581 | O95785 | |
| KLEGIPAYIVVPQTA | 96 | Q9GZT4 | |
| PVNPNTLKEGYISVN | 821 | Q86SQ0 | |
| KPGVYAVSVTGRLPQ | 81 | P63272 | |
| KNGGVKPNIIPSYSE | 256 | Q8IYS1 | |
| IAKPQGTYQVLPPNT | 1521 | Q6Q759 | |
| SKIGVFPGNYVAPVT | 491 | Q7Z6J0 | |
| VYPVAGGPTFKRINV | 431 | O95025 | |
| PENVIIYGQSIGTVP | 161 | Q5VST6 | |
| VLKLQPQTYSPGEYV | 361 | Q8IV77 | |
| TKIPVIENPQYFGIT | 506 | Q16620 | |
| YVIQAPKGGQKISPD | 1546 | Q63HN8 | |
| SNPVAKIIYGDPVTF | 4711 | Q63HN8 | |
| FKVGINYQPPTVVPG | 351 | P0DPH8 | |
| KGYALVPIIVNSSTP | 351 | P82094 | |
| FVPKPVATTLQYVGG | 1396 | Q8IZQ1 | |
| VKLTPAQYQGLSGSP | 261 | Q9C0A1 | |
| VIVNQYVIRPGPSAS | 116 | Q9H0X6 | |
| PVPKIFYVQLTVGNN | 141 | Q9NUL3 | |
| PGPISKYVVEVQVAG | 671 | P35590 | |
| VGPGSYQVPFLKQQA | 21 | Q8N412 | |
| LPNYATINGKVSSPV | 1401 | Q9HBL0 | |
| FKVGINYQPPTVVPG | 351 | P0DPH7 | |
| YPGQVLIGPAKIFSS | 261 | Q9C0C9 | |
| IVTKNTLPGVGPYES | 91 | Q96GE5 | |
| VPGVEYPVGKHAVQT | 1386 | Q9P273 | |
| PQQPSLGGVYKLVAV | 386 | Q6XQN6 | |
| TVTTQLGPYAFKIPL | 846 | Q8IZJ1 | |
| YVASGPKTTQLLPVV | 396 | Q495X7 | |
| AGPVKAGVTQTPRYL | 16 | A0A578 | |
| FISGYQTPTGLSPVK | 271 | Q8N4Q0 | |
| GTVIYQCLVGKPPFQ | 201 | Q8IYT8 | |
| LVAPVSPYKPGQTVF | 336 | Q96F45 | |
| DAAPLPTVVYSKGLQ | 976 | Q8N398 | |
| PTVVYSKGLQRGSPA | 981 | Q8N398 | |
| ISIVAYKQVPLSPYG | 456 | Q9BY10 | |
| PYQAVGLVQGTTPVL | 431 | O43175 | |
| FKVGINYQPPTVVPG | 351 | Q71U36 | |
| FKVGINYQPPTVVPG | 351 | Q6PEY2 | |
| VVYVPPQIGEKSLIS | 416 | P35968 | |
| LVPGNKLVFSSYPGT | 291 | Q8NHP8 | |
| NPGKTPISLLQEYGT | 26 | Q15633 | |
| FSIKQSIEPPSGIYG | 1136 | Q9Y4F4 | |
| IQSITSYLGPPIAAV | 456 | P13866 | |
| FKVGINYQPPTVVPG | 351 | P68363 | |
| SKPVTYATVIFPGGN | 276 | Q86YW5 | |
| DYINVVPTAGPLAQK | 596 | Q96LC7 | |
| PQVFYKGLAPTLIAI | 171 | Q9HC21 | |
| FKVGINYQPPTVVPG | 351 | Q9BQE3 | |
| VVPAGLTYSTFVPLQ | 2406 | P15822 | |
| YQKRPVLGDIVSGPV | 1281 | Q562E7 | |
| FKVGINYQPPTVVPG | 351 | Q9NY65 | |
| FKVGINYQPPTVVPG | 351 | P68366 | |
| AASQSPLPQYVTVKG | 606 | Q9ULM3 | |
| SVPPTLTPKQGYFLQ | 751 | A6NNM8 | |
| VIAYGPSQVKPPAVQ | 261 | Q9P2D8 | |
| NKVPPNGLVVYCGTI | 86 | P62495 | |
| IRVKQALATPSAPYG | 691 | Q5VTT5 | |
| NPPDIVGKTSQVTLY | 131 | P25189 | |
| KGNEIPQTIAPSTYV | 536 | O60237 |